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THICK FILAMENT REGULATION OF MYOCARDIAL CONTRACTION 
 
 
ABSTRACT 
 
The ability of the heart to function as a pump is governed by mechanisms intrinsic 
to individual cardiac myocytes.  These mechanisms include, but are not limited to, 
amount of activator Ca2+ released, sensitivity of the myofilaments to Ca2+, and the kinetic 
cycling rates of motor isozymes.  All of these mechanisms have the potential to be altered 
either on a beat-to-beat basis by factors such as sarcomere length or post-translational 
modification or on a long-term basis through changes in protein isoform expression.  
Single skinned cardiac myocytes provide an ideal platform for study of these factors 
because they allow precise control of the ionic milieu bathing the myocyte and protein 
isoform content can be determined for each myocyte following mechanical 
measurements.  The experiments in this dissertation were designed to examine the effects 
of sarcomere length and thick filament protein isoform expression on the contractile 
properties of single skinned cardiac myocytes. 
 Myosin binding protein-C (MyBP-C) is a thick filament protein that is thought to 
have structural and regulatory effects, and mutations in the gene encoding MyBP-C are 
among the most commonly identified with familial hypertrophic cardiomyopathy.  I 
examined the effect of MyBP-C ablation (MyBP-C-\-) on mechanical properties in mouse 
skinned cardiac myocytes.  Peak normalized power output at maximal Ca2+ activation 
was significantly elevated in myocytes from MyBP-C-\- myocardium, while isometric 
force and rate of force development were unchanged.  At submaximal Ca2+ activation, 
however, the rate of force development was significantly elevated and peak normalized 
 vii
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power output was increased to an even greater extent.  From these data it is concluded 
that MyBP-C regulates myocardial contractility by limiting crossbridge kinetics. 
 Sarcomere length (SL) is also an important regulator of myocardial performance, 
as increased SL within the physiologic-al range is known to increase isometric force 
production.  Myocytes in vivo, however, are shortening against a load and the effects of 
SL on loaded shortening velocity have not been determined.  Data presented here 
examined the effect of SL on force, rate of force development, loaded shortening 
velocity, and power output in rat skinned cardiac myocytes.  Furthermore, the effects of 
SL on myosin heavy chain dependence (MyHC) mechanical properties were examined in 
myocytes containing primarily either αMyHC or β-MyHC, which are the two types of 
MyHC expressed in the heart.  Peak absolute and normalized loaded shortening velocity 
and power output at short SL in both α-MyHC and β-MyHC myocytes.  Matching 
myocyte force between long and short SL, however, sped loaded shortening -velocity and 
increased power output in α-MyHC myocytes to values greater than at long SL, but this 
did not occur in β-MyHC.  Matching myocyte width between long and short SL sped 
loaded shortening velocity and increased power output to values greater than at long SL 
in both α-MyHC and β-MyHC myocytes.  Effects of SL and MyHC on rate of force 
development and Ca2+ sensitivity were also determined.  From the data, it is concluded 
that there is an increase in crossbridge kinetics at short SL as compared to long SL, which 
is overcome by increased lattice spacing induced decrease in actomyosin interactions.  
The data are presented in terms of a model whereby SL shortening induces a 
conformational change in MyBP-C that removes its constraint on the myosin heads, 
allowing them to cycle faster. 
Chapter 1.    INTRODUCTION 
 
 
1.1 Cardiac Function and Ultrastructure 
 
 In 1628 William Harvey published “On the movement of the heart and blood in 
animals”, wherein he was the first to describe the heart as a pump that circulates blood 
within a closed system [56]; a discovery that is considered the foundation for modern 
cardiovascular research.  The heart pumps to provide oxygen and nutrients necessary to 
organ and organismal survival, and it does so by cyclic contraction and relaxation of 
cardiac muscle, a unique form of striated muscle similar to but also quite distinct from 
skeletal muscle.  The mammalian heart has four chambers: two ventricles and two atria 
with a bilateral distribution such that the right side, which comprises the low pressure 
pulmonary circulation, and the left side, which provides high pressure systemic 
circulation, each have an atrium and ventricle.  The two sides work against much 
different arterial pressures but, because the circulatory system is a closed loop, 
volumetric output from one side must match the other.  The matching of ventricular 
outputs is described by the Frank-Starling mechanism, whereby increased blood flow to a 
ventricle results in a more forceful ejection of blood.  A major focus of study in this 
dissertation is potential myofibrillar mechanisms that regulate this process.   
 
The heart’s function as a pump can be divided into four distinct phases, which is 
well illustrated using a modified Wiggers diagram that shows changes in left ventricular 
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pressure and volume over time (Figure 1.1).  Phase 1 is filling, where the pressure in the 
ventricle is very low but the volume of blood in the ventricle is rising.  Electrical 
stimulation initiates contraction, normally starting from the sino-atrial node (SA node).  
The SA node is a cluster of specialized pacemaker cells located in the upper right atrium 
near the entrance of the superior vena cava, and their electrical signal is propagated first 
through the atrium and then through the atrioventricular node (AV node) and then to the 
ventricles.  The fact that the atria are stimulated slightly before the ventricles is 
significant because it results in an “atrial kick”, which can be seen on the left ventricular 
pressure-volume relationship as the increase in both volume and pressure near the end of 
the filling phase.  The atrial kick accounts for up to as much as 1/3 more blood volume 
filling the ventricle [6], which, in accordance with Starling’s Law, accounts for 15-30% 
of ventricular stroke volume.  Electrical excitation of the ventricles initiates phase 2 of 
the cardiac cycle, isovolumic contraction.  Pressure rapidly rises in the ventricles, which 
causes the atrioventricular valve to close, but ventricular pressure remains below aortic 
pressure so the aortic semilunar valve remains closed.  Since blood cannot enter or leave, 
the volume of blood in the ventricle, also known as end-diastolic volume (EDV), remains 
constant during phase 2.  Pressure will continue to rise in the ventricle until it exceeds 
aortic pressure at which point the aortic semilunar valve will open and phase 3, or 
ejection, will commence.  During ejection, the heart is contracting against the load 
imposed, in part, by the arterial resistance.  As the myocardium shortens and the volume 
of blood in the ventricles is decreased, the ventricular pressure starts to decline.  When 
ventricular pressure falls below the pressure in the aorta, the aortic valve closes and the  
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Figure 1.1: Wiggers Diagram of the Cardiac Cycle in Human Left Ventricle. 
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left ventricle now undergoes isovolumic relaxation, the fourth phase of the cardiac cycle.  
The volume of blood in the ventricle at this point is called end-systolic volume (ESV).  
The volumetric difference between EDV and ESV is known as stroke volume (SV) (i.e., 
the amount of blood ejected during systole).  The product of stroke volume and heart rate 
(HR) is termed cardiac output (CO), and is a major index of ventricular function.   
 
In 1895 Otto Frank showed that a frog ventricle developed more pressure as end-
diastolic pressure increased  (a phenomenon that may have been observed as early as 
1866 [190]), while in 1914 Ernest Starling demonstrated, in an isolated heart-lung 
preparation from a dog, that cardiac output (SV x HR) increases coincident with venous 
filling pressure .  These observations have since become known as the Frank-Starling 
relationship (Figure 1.2), whereby increased end-diastolic volume leads to an increased 
stroke volume, and it is recognized as essential in beat-to-beat regulation of heart 
contractility and ventricular function.  To understand how an increase in end-diastolic 
volume can lead to an increase in the forcefulness of contraction first requires an 
understanding of the functional anatomy of the heart.   
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 Figure 1.2 
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Figure 1.2: Ventricular Function Curve 
A ventricular function curve illustrates the Frank-Starling relationship.  At constant heart 
rate and ejection pressure, stroke volume increases with rising end-diastolic volume.  
Impairment of this relationship (i.e., a shallower curve) is associated with heart failure. 
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1.2 Structure of the Myocardium 
 
The working myocardium is primarily composed of individual cardiac myocytes.  
Myocytes are typically mononucleated cells approximately 120 µm in length and 30 µm 
in width,  and are arranged in overlapping sheets of muscle that spiral from the base of 
the heart to the apex in such a manner that the endocardial surface spirals in a counter 
right-handed helix and myocytes tend to be circumferentially oriented while the 
epicardium forms a left-handed helix from the apex to the base and the myocytes are 
perpendicularly oriented to the base-apex axis at the epicardial surface (Figure 1.3).  This 
orientation of myocardial fibers lends a torsional aspect to contraction that effectively 
adds a wringing motion that results in more efficient chamber squeezing and propulsion 
of blood and is thought to equalize stress and strain throughout the heart [167], and likely 
has consequences for regulation through stretch-activation [16] (see discussion).  
Neighboring myocytes are connected mechanically by intercalated discs and electrically 
by gap junctions that allow rapid propagation of ions and action potentials.  Thus, the 
heart acts as a functional syncytium with all working myocytes contracting in near 
synchrony.  Because of this, myocardial function is not altered by recruitment of more or 
fewer muscle cells as occurs in skeletal muscle, but rather by factors intrinsic to the 
individual myocytes.  Myocytes have a characteristic striation pattern, which arises from 
the orderly longitudinal arrangement of cylindrical bundles of thick and thin filaments 
called myofibrils (Figure 1.3).  The functional unit of the myofibril is the sarcomere, 
which extends from one Z-line to another.  The Z-line anchors the thin filament, which 
interdigitates with the thick filament that extends in each direction from the  
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Figure 1.3 
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 Figure 1.3: Cardiac Structure (previous page) 
 
A. The myocardial fibers align angularly throughout the ventricular wall (top) and also 
show a spiral arrangement from epicardium to endocardium as they sweep from the apex 
of the left ventricle (taken from Pettigrew, 1908 [138].  B. Illustration of myocyte 
arrangement within the myocardium.  C. Photomicrograph of a single cardiac myocyte.  
D. Electron micrograph of the internal structure of a myocyte detailing the individual 
myofibrils and mitochondria that comprise the bulk of a myocyte.  E. Electron 
micrograph of a single sarcomere, the functional unit of muscle (taken from Winegrad, 
1999 [183].  The sarcomere runs from Z-disk to Z-disk.  F. Illustration of the hexagonal 
arrangement of thick and thin filaments when viewed in cross-section. 
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middle of the sarcomere called the M-line.  A cross section of this assembly shows that 
each thick filament is surrounded by six thin filaments that lie at trigonal points between 
neighboring thick filaments.  The region where the thin filament does not overlap with 
the thick filament is called the I-band because it is isotropic and does not polarize light, 
whereas the region where the thick and thin filaments do overlap is strongly birefringent 
and is called the A-band (anisotropic).  There is also a distinct region with the A-band 
called the C-zone, where the thick filament protein myosin binding protein-C (MyBP-C) 
aggregates.  The thick filament is approximately 1.65 um in length, while the thin 
filament extends 1.0 um from the Z-disc.  Increasing the sarcomere length over the 
working range of the myocardium leads to more optimal overlap of thick and thin 
filaments [43].  Returning to the Frank-Starling relationship, the anatomical result of an 
increase in EDV is a stretching of the ventricular myocardium, which lengthens 
individual myocytes and the sarcomeres contained within the myocytes.  In maximally 
Ca2+-activated skinned cardiac cells, more optimal overlap leads to greater force 
generating capacity [28].  However, the steepness of the SL-force relationship in cardiac 
muscle is too great to be solely due to extent of thick and thin filament overlap.  In fact, 
the steepness of this relationship increases as Ca2+ activation level decreases [3, 88, 173].  
This is important because, unlike skeletal muscle which typically sees maximal Ca2+ 
activation, the myocardium in vivo operates at approximately half-maximal Ca2+ 
activation [2, 5, 27].  At increasing SL, there is both increased calcium release from the 
sarcoplasmic reticulum [5] and increased myofilament calcium sensitivity [5, 66, 79, 
101].  Thus, there are intrinsic myofibrillar mechanisms that detect and respond to 
changes in SL on a beat-to-beat basis. 
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1.3 Thin Filament Structure and Function 
 
 The thin filament is primarily composed of actin monomers (G-actin) that 
polymerize to form F-actin filaments.  Two actin filaments intertwine in a 
macromolecular helical arrangement to form the thin filament backbone, and each half-
turn of the thin filament helix contains 7 actin monomers.  This is noteworthy because the 
dimeric filamentous molecule tropomyosin (Tm) spans 7 actin monomers as it binds to 
the actin filament and lies in the groove between the two strands of actin.  This provides 
additional structural integrity to the thin filament and positions Tm for regulation of 
contraction, which it does in conjunction with the troponin complex.  The troponin (Tn) 
complex is comprised of three subunits; TnI, TnT, and TnC.  TnC contains a Ca2+ 
binding site that, when bound with Ca2+, causes a conformational change that relieves the 
crossbridge inhibitory property of TnI.  TnT binds the troponin complex to tropomyosin.  
This complex of proteins (7 actin monomers, Tm dimer, Tn complex) forms the structural 
regulatory unit of muscle, which can undergo further regulation by post-translational 
modification.  For example, the cardiac isoform of TnI contains a NH2-terminal extension 
(which is absent in skeletal TnI) that contains two phosphorylation sites (Ser 23/24) for 
cAMP-dependent protein kinase (PKA) associated with a decrease in Ca2+ sensitivity of 
the myofilaments [147].  cTnI also contains PKC phosphorylation sites (Ser 43/45, Thr 
144) that are associated with decreased myosin ATPase rate [94, 126], as is PKC 
phosphorylation of cTnT [127, 128, 170].  The thick filament is discussed in more detail 
below, but is primarily composed of myosin and myosin binding protein-C and is 
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attached to the Z-disk by the giant filamentous protein titin (also known as connectin).  
The sarcomeric proteins are illustrated in Figure 1.4. 
 
A key aspect of cardiac muscle function is the relationship between isometric 
force and the concentration of activator Ca2+.  A current model of contractile regulation 
proposes that the regulatory unit of the thin filament exists in three distinct states, each 
depending on the relative position of the regulatory protein tropomyosin [42].  In the 
absence of Ca2+, and thus absence of contraction, the thin filaments are thought to be in a 
“blocked” state where tropomyosin sterically prevents myosin from interacting strongly 
with actin.  Upon the addition of Ca2+ and its subsequent binding to the regulatory protein 
troponin C, there is a conformational change in troponin I (TnI) that causes tropomyosin 
to reduce its steric inhibition, allowing a weakly-bound actomyosin interaction in what is 
known as the “closed state”.  Populations of weakly interacting actomyosin cross-bridges 
then undergo a transition to strongly bound but non-force generating cross-bridges that 
force tropomyosin into the groove of the actin filament initiating an “open” state that 
allows the strongly-bound cross-bridges to isomerize to force-generating states.  In fact, 
this displacement of Tm by strong crossbridges has been shown to spread to adjacent 
regulatory units [146], illustrating the highly cooperative behavior of the thin filament. 
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As noted previously, increases in SL result in increased Ca2+ sensitivity.  
Specifically, this increased Ca2+ sensitivity is associated with an increase in Ca2+ affinity 
for the Ca2+ binding site on cardiac TnC (cTnC) [66, 67], which led to speculation that 
cTnC is the length sensor in cardiac muscle [8].  However, neither substitution of cTnC 
into skeletal muscle [119] nor expression of skeletal TnC in cardiac myocytes [101] 
altered the length dependence of Ca2+ sensitivity of tension.  It is important to note that 
full activation of thin filaments requires both Ca2+ and strongly-bound myosin cross-
bridges.  For this reason, length dependence likely involves regulation, at least in part, by 
the thick filament. 
 
1.4 Thick Filament Structure and Function 
 
The major component of the thick filament is myosin, a highly asymmetrical 
hexameric protein consisting of two myosin heavy chains (MyHCs) and two pairs of 
myosin light chains (MLCs) for a total molecular weight of approximately 520 kDa.  
Each heavy chain is between 200-240 kDa, with a globular “head” at the N-terminus of 
the protein and an α-helical C-terminal “tail” that interacts with another MyHC in a 
coiled-coil motif.  This coiled-coil intertwines to form a left-handed superhelix that 
makes up the rod portion of myosin, which interacts with other rod portions of myosin to 
make up the backbone of the thick filament.  Myosin can be proteolytically cleaved to 
yield two subfragments termed heavy meromyosin (HMM) and light meromyosin 
(LMM) (Figure 1.5). 
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Figure 1.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Illustration of Myosin and Myosin Fragments and Subunits 
A.  Illustration of the myosin molecule consisting of four light chains and two heavy 
chains with globular heads and an α-helical coiled-coil tail.  Enzymatic cleavage with 
trypsin yields the low salt soluble heavy meromyosin (B) and the low salt insoluble light 
meromyosin (C).  (Taken from Wick [182]) 
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HMM is composed of the two globular head and neck regions of MyHC termed 
subfragment-1 (S-1) that contain both the actin binding site and the ATP binding and 
catalyzing site, and a short part of the double stranded α-helical tail called subfragment 2 
(S-2).  LMM is the remaining two-thirds of the α-helical tail region.  The two pairs of 
light chains consist of one pair of regulatory light chains (RLC) and one pair of essential 
light chains (ELC).  ELC is thought to be required for normal actin-activated ATPase 
activity.  Evidence suggests that it does so by providing stability to MHC by binding at 
the head-rod junction, also called the neck region that is thought to function as a “lever 
arm” for force generation.  RLC also is thought to provide stability to the neck region of 
myosin, but can also regulate ATPase activity via phosphorylation by myosin light chain 
kinase (MLCK).              
 
There are two types of myosin heavy chains expressed in the myocardium of 
mammals; α-MyHC and β-MyHC.  Hoh et al., [70] were the first to discover three 
isozymes of cardiac myosin termed V1, V2, and V3 based on decreasing electrophoretic 
mobility.  It was later determined that V1 and V3 are homodimers of α- and β-MyHC 
respectively, while V2 is a heterodimer of α- and β-MyHC.  The expression of the MyHC 
isoforms is closely regulated in mammals, with β-MyHC being the dominant isoform 
expressed during early development of all mammals.  β-MyHC remains high throughout 
life in humans, with α-MyHC comprising only ~10% of total MyHC protein [109, 154] 
despite α-MyHC mRNA representing ~35% of total ventricular MyHC mRNA [93, 121].  
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Rodents, on the other hand, experience a shift to α-MyHC around birth that remains high 
throughout life with some reversion to β-MyHC with age.   
 
Increases in β-MyHC also are seen in pathophysiological conditions such as 
pressure overload [90, 92, 95], diabetes [25, 38], and hypothyroidism [22, 40, 115] in 
rodents.  There is strong evidence that this is also the case in human myocardium where 
the small amount of α-MyHC (~10%) is replaced with β-MyHC in heart failure [109].  
This appears to be functionally significant as it has been shown that a loss of as little as 
~12% α-MyHC reduced power output by ~50% in rat single cardiac myocytes [62], 
although it has been postulated that this switch to β-MyHC is energetically favorable as it 
increases economy (i.e., force per ATP hydrolyzed) [50, 71, 91, 151, 168].  More recent 
evidence, however, suggests that α-MyHC may be as much as 70% of total MyHC in 
neonatal and young adult human myocardium, which diminishes with age [58].   
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These isozymes are highly homologous with 93% amino acid sequence homology [106].  
Structurally, the amino acid changes most likely to account for mechanical differences 
are known to occur in the actin binding pocket, the ATP binding pocket, the neck region 
near ELC, the neck region near RLC, and in the rod segment of myosin [7] (illustrated as 
arrows in Figure 1.6).  These few amino acid changes yield vast differences in the 
enzymatic and mechanical properties they convey on muscle.  Myocytes containing 
100% α-MyHC were shown to generate ~170% greater peak normalized power output 
than myocytes containing 100% β-MyHC [60, 85].  Similarly, α-MyHC has been shown 
to exhibit ~3 times higher actin activated ATPase activity and actin filament sliding  
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Figure 1.6: Crystal Structure of Chicken Myosin 
 
Crystal structure of chicken myosin heavy chain, taken from Rayment et al., [143] 
illustrating the major domains of myosin heavy chain with points of amino acid 
differences between α-MyHC and β-MyHC indicated with arrows. 
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velocity than β-MyHC [141, 176, 184], and 2 to 6 times faster maximum shortening 
velocities in myocardial preparations [24, 30, 131].  β-MyHC, however, has been 
reported to produce twice the crossbridge force per ATPase cycle as α-MyHC, meaning it 
requires less energy consumption to maintain a given force (i.e., a lower tension cost) as 
noted above [50, 71, 91, 151, 168].  Expression of β-MyHC may therefore be 
energetically favorable for failing myocardium, but may compromise cardiac output due 
to slower rates of the rise of force [31, 32, 151], which would slow pressure development.  
β-MyHC also has slower myocardial shortening velocities [31, 32, 59, 60, 85, 131, 156], 
which would lessen ejection volume.  Increased β-MyHC content also appears to be 
tightly correlated with slower heart rate across species, which may further compromise 
cardiac output (HR x SV).  However, a slower heart rate also increases the time for 
ventricular filling, which would increase end-diastolic volume and lead to a more forceful 
ejection in accordance with the Frank-Starling relationship.  Due to loss of sympathetic 
activation associated with heart failure [172], a failing heart must rely primarily on 
Starling’s law to achieve more forceful contractions.  Teleologically, it may be possible 
that β-MyHC is more responsive to changes in sarcomere length than α-MyHC as a 
compensatory mechanism to rely on changes in SL to tune power under more economical 
conditions.  Experiments in this study were designed to test this novel hypothesis. 
 
 Different chemomechanical states in the cross-bridge cycle appear to 
differentially affect thin filament activation.  Cycling cross-bridges have been reported to 
increase Ca2+ binding affinity to a greater degree than rigor cross bridges[13, 48].  As α-
MyHC and β-MyHC exhibit different cross-bridge cycling rates, there is the possibility 
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that isometric tension-[Ca2+] relationships are dependent on MyHC isoform content.  
Studies of this possibility have produced conflicting results.  For example, a study that 
compared saponin-treated bundles of rabbit myocardium expressing either α-MyHC or β-
MyHC showed no difference in the force-pCa relationships [132], whereas ventricular 
bundles from hypothyroid rats containing primarily β-MyHC were left-shifted (i.e., more 
sensitive to Ca2+) compared to bundles from euthyroid α-MyHC rats containing primarily 
α-MyHC [40].  Single myocyte experiments have yielded no shift [30] or a rightward 
shift (less sensitivity to Ca2+) in myocytes from hypothyroid rats [107].  The reasons for 
these discordant results are not known but may be due to undetected variations in the 
degree of protein kinase A (PKA) and/or protein kinase C (PKC) induced 
phosphorylation of myofibrillar proteins between the groups.  PKA phosphorylation of 
serines 23 and 24 on TnI is known to decrease Ca2+ sensitivity of force in myocardial 
preparations [77, 166, 179], while PKC apparently increases Ca2+ sensitivity by 
phosphorylating TnI at serines 43 and 45 and threonine 144 [139]. 
 
Another confounding factor may be phosphorylation of troponin T (TnT), which 
binds to tropomyosin and acts as a molecular interface between tropomyosin and 
TnI/TnC.  The functionally critical phosphorylation site on TnT may be Thr206, which 
was preferentially phosphorylated by PKCα and resulted in decreased Ca2+ sensitivity 
[169].  PKA and PKC both phosphorylate the thick filament regulatory protein myosin 
binding protein-C (MyBP-C) but at the same sites [178].  The role of MyBP-C in Ca2+ 
sensitivity is not known but mice lacking MyBP-C showed decreased Ca2+ sensitivity 
[51].  Furthermore, myosin light chain 2 (RLC) is phosphorylated by PKC, which results 
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in increased Ca2+ sensitivity[78].  An inverse correlation also was found between the 
percentage of phosphorylated MLC2 and pCa50 in donor and failing human hearts[175], 
whereas other studies show only modest changes in MLC2 phosphorylation with changes 
in Ca2+ sensitivity arising from TnI phosphorylation[139].  Clearly, regulation of Ca2+ 
sensitivity is a complex interaction between a number of myofibrillar proteins that need 
to be controlled for as carefully as possible when assessing Ca2+ sensitivity of force in 
cardiac muscle.  The experiments performed in this dissertation attempted to determine if 
myocytes containing α-MyHC or β-MyHC have different Ca2+ sensitivity of force, 
working under the hypothesis that previously seen differences in Ca2+ sensitivity of force 
were due to undetected differences in myofibrillar protein phosphorylation levels.  
Tension-pCa relationships were compared between skinned myocytes expressing either 
100% α-MyHC or 100% β-MyHC in which the level of myofibrillar phosphorylation 
was at least partly controlled by incubating the myocytes with the catalytic subunit of 
PKA. 
 
  
 Another major component of the thick filament is myosin binding protein-C 
(MyBP-C).  MyBP-C is a “C” shaped protein found at 43 nm repeats in a segment of the 
A band called the C zone (see Figure 1.3E) in both skeletal and cardiac muscle [9].  It 
consists of 10 distinct domains (termed C1 through C10), 7 fibronectin and 3 
immunoglobin, but the cardiac isoform contains an additional immunoglobin segment at 
the N terminus (termed C0) and a 105 amino acid residue linker between C1 and C2 
called the MyBP-C motif [130].  The MyBP-C motif carries 3 phosphorylation sites 
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unique to the cardiac isoform that can be phosphorylated by PKA and PKC, and has also 
been shown to interact with the S2 segment of myosin [39].  MyBP-C was long thought 
to be a structural element as its carboxy terminus binds and interacts with the rod portion 
of myosin [41] and titin [33].  Synthetic myosin filaments show increased uniformity and 
decreased diameter in the presence of MyBP-C [84], while cardiac muscle cells 
expressing truncated MyBP-C have increased disorder and myofibrillar disarray [188].  
Interestingly, x-ray diffraction patterns suggest that there are changes in MyBP-C 
structure and myosin backbone arrangement during contraction [69, 73, 162], underlining 
the intimate interaction between MyBP-C and myosin.  More recent evidence suggests 
that the C5 and C8 domains, and to a lesser extent the C7 and C10 domains, of 
neighboring MyBP-Cs preferentially interact with each other, leading to the hypothesis 
that MyBP-C forms a trimeric “collar’ that wraps around the thick filament [110] (Figure 
1.7).  In this arrangement, it is well positioned to provide structural integrity to the 
backbone of the thick filament, as well as to provide potential regulatory action on titin, 
actin, and the myosin heads.  Functionally, addition of MyBP-C to cardiac myosin 
increases the ATPase activity at all ionic strengths [155].  Importantly, the entire myosin 
molecule must be present for this change in ATPase activity to occur [55, 96, 112], 
suggesting that ATPase activity is influenced by the rod portion of myosin.  Removal of 
RLC abolishes the MyBP-C induced increase in ATPase activity, while restoration of 
RLC also restores this effect [96].  Thus, MyBP-C may be interacting with RLC to affect 
the ATPase rate of myosin, which makes sense considering that MyBP-C is thought to 
bind at the hinge region of myosin very near RLC [114, 162].  In terms of contractile 
function, it has been suggested that MyBP-C contributes to an internal load because  
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Figure 1.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Proposed Trimeric Collar for MyBP-C 
 
MyBP-C forms a collar around the rod portion of the thick filament backbone, providing 
structural support and potential crossbridge regulation (taken from Moolman-Smook et 
al., 2002) [110]. 
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partial extraction resulted in an increase in maximal shortening velocity (Vmax) at 
submaximal Ca2+ concentrations [68, 69].  Partial extraction of MyBP-C also resulted in 
an increase in submaximal force with no change in maximal force, which was reversible 
when MyBP-C was restored [68, 118].  Phosphorylation of MyBP-C by PKA is thought 
to reduce the interaction between MyBP-C and the S2 segment of myosin, and PKA is 
known to increase loaded shortening velocity and power output in skinned cardiac 
myocytes [61].  Furthermore, disruption of the interaction between MyBP-C and S2 
enhanced myocyte shortening [15] and increased Ca2+ sensitivity of force in skinned 
myocardium [87, 185].   Together, these results imply that MyBP-C acts as a “brake” to 
limit contractility.  However, PKA also phosphorylates TnI, necessitating a separation of 
the effects of TnI phosphorylation from MyBP-C phosphorylation.  Experiments 
performed here utilized a transgenic mouse model of MyBP-C to test the hypothesis that 
myocytes lacking MyBP-C would have increased loaded shortening velocity, power 
output, and rates of force development due to lack of restraint normally imposed by 
MyBP-C on crossbridge kinetics. 
 
1.5 Sarcomere Length Dependence of Myocardial Function 
 
 The Frank-Starling mechanism is an important determinant of cardiac output, and 
failure of this mechanism will inevitably lead to fluid buildup such as pulmonary edema 
or inadequately supply peripheral tissue leading to organ failure.  Furthermore, there is 
significant evidence demonstrating that the Frank-Starling mechanism is compromised in 
human [72, 80, 157] and other animal models of heart failure [76, 81, 123, 150].  As 
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discussed above, the cellular basis for the Frank-Starling mechanism involves an 
enhancement of force and Ca2+ sensitivity of force [4, 5, 43, 66, 79, 101].  Interestingly, a 
recent study showed that the rate of force development was actually faster at short SL 
when the difference in isometric force was normalized in rat skinned cardiac trabeculae 
[1].  The experiments presented in this dissertation measured the rate of force 
development at long and short SL with and without matched isometric forces.  While 
many studies involving the Frank-Starling relationship have focused on the steady-state 
measurement of force, there have been few studies that addressed myocardial shortening, 
most of which measured unloaded shortening velocity.  Early studies indicated that 
unloaded shortening velocity in frog skeletal fibers was independent of SL, but these 
experiments were performed at maximal Ca2+ activation [26].  A more recent study using 
ferret papillary muscle showed SL dependence of muscle segment shortening under very 
lightly loaded contractions [97].  This also was seen in rat cardiac trabeculae activated at 
submaximal Ca2+ levels where unloaded shortening velocity correlated with SL; the 
authors speculated the unloaded shortening velocity is limited by an internal passive 
viscoelastic element, such as titin [24].  Myocytes in vivo, however, undergo shortening 
against an afterload and there is a dearth of literature regarding the effects of sarcomere 
length on the dynamic measurement of shortening against a load.  Thus, we examined SL 
dependence of loaded shortening velocity and power output.  Additionally, SL was 
monitored and recorded during these measurements to provide as thorough a 
characterization of sarcomeric shortening velocity as possible.  Potential subcellular 
mechanisms that regulate SL responsiveness also were examined.  As a myocyte 
shortens, the distance between the thick and thin filament, known as the interfilament 
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lattice space, increases [74, 98, 149].  Similar changes have also been observed in 
myocardium in situ [137].  The result of an increase in lattice spacing is that the distance 
between actin and the myosin heads is increased, thereby decreasing the likelihood of 
crossbridge interaction.  Conversely, decreasing the interfilament distance by increasing 
SL enhances the probability of crossbridge interaction.  Similarly, decreasing the 
interfilament spacing independent of SL by osmotic compression has been shown to 
increase force, enhance Ca2+ sensitivity, and speed loaded shortening velocity [54, 82, 
101].  Shortening velocity is likely increased due to elevated levels of thin filament 
activation arising from increased numbers of strongly bound myosin crossbridges [99, 
103].  Thus, we also examined SL dependence of sarcomeric shortening velocity and rate 
of force development at matched thin filament activation levels indexed by isometric 
force or matched lattice spacing indexed by myocyte width. 
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Chapter 2: LOADED SHORTENING, POWER OUTPUT, AND RATE OF 
FORCE REDEVELOPMENT ARE INCREASED WITH 
KNOCKOUT OF CARDIAC MYOSIN BINDING PROTEIN-C 
 
 
 
ABSTRACT 
 
Myosin binding protein-C (MyBP-C) is localized to the thick filaments of striated 
muscle where it appears to have both structural and regulatory functions.  Importantly, 
mutations in the cardiac MyBP-C gene are associated with familial hypertrophic 
cardiomyopathy.  The purpose of this study was to examine the role that MyBP-C plays 
in regulating force, power output, and force development rates in cardiac myocytes.  
Skinned cardiac myocytes from wild type (WT) and MyBP-C knock-out (MyBP-C-/-) 
mice were attached between a force transducer and position motor.  Force, loaded 
shortening velocities, and rates of force redevelopment were measured during both 
maximal and half-maximal Ca2+ activations.  Isometric force was not different between 
the two groups with force being 17.0 ± 7.2 kN/m2 and 20.5 ± 3.1 kN/m2 in wild type and 
MyBP-C-/- myocytes, respectively.  Peak normalized power output was significantly 
increased by 26% in MyBP-C-/- myocytes (0.15 ± 0.01 versus 0.19 ± 0.03 P/Po*ML/sec) 
during maximal Ca2+ activations.  Interestingly, peak power output in MyBP-C-/- 
myocytes was increased to an even greater extent (46%, 0.09 ± 0.03 versus 0.14 ± 0.02 
P/Po*ML/sec) during half-maximal Ca2+ activations.  There was also an effect on the rate 
constant of force redevelopment (ktr) during half-maximal Ca2+ activations, with ktr being 
significantly greater in MyB-C-/- myocytes (WT = 5.8 ± 0.9 s-1 vs. MyBP-C-/- = 7.7 ± 1.7 
s-1).    These results suggest that cMyBP-C is an important regulator of myocardial work 
capacity whereby MyBP-C acts to limit power output. 
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INTRODUCTION 
 
 
Myosin binding protein-C (MyBP-C) is a thick filament associated protein [129] 
that is present in vertebrate striated muscle, and mutations in the cardiac MyBP-C gene 
have been implicated in the development of some familial hypertrophic cardiomyopathies 
(FHC) [171].  Although the exact role of MyBP-C in muscle development and function is 
unclear, it has been postulated that MyBP-C plays both structural and regulatory roles 
[183].  The role of MyBP-C as a structural element involves its carboxy terminus binding 
to the thick filament where it interacts with both the rod portion of myosin [41] and titin 
[33].  These C-terminal interactions are thought to stabilize the structure of the thick 
filament and produce a more ordered arrangement of myosin heads.   Moolman-Smook et 
al., have provided evidence that the immunoglobulin-like domains C5 and C8 of MyBP-
C preferentially interact with each other, which taken together with previous structural 
and biochemical data led them to propose that MyBP-C molecules form a collar around 
the backbone of the thick filament [110].  They speculated that the collar packs the 
backbone more tightly and restricts actin-myosin interactions, whereas release of the 
collar would result in a looser backbone and perhaps enhance cross-bridge formation.  
Additionally, mutations in the MyBP-C gene that produce C-terminal truncated proteins 
have been found to result in acute changes in structure not only at the myofilament, but 
also in the structure of the heart that ultimately leads to impaired myocardial performance 
[19].  Cardiac MyBP-C (cMyBP-C) also contains a unique immunoglobulin-like domain 
at the N-terminal portion of the protein termed C0 [19] and a distinct region between two 
Ig-like domains (C1 and C2), which is termed the MyBP-C motif [39].  This motif has 
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been shown to bind to the S2 segment of myosin near the lever arm domain of the myosin 
head, and this interaction is modified in response to phosphorylation of the MyBP-C 
motif by cAMP-dependent protein kinase (PKA) [39, 46].  Mutations in the cardiac 
MyBP-C gene that lead to changes near the N-terminus have also been linked to familial 
hypertrophic cardiomyopathy [125].   
 
Recently, targeted ablation of the cMyBP-C gene was used to produce mice 
lacking MyBP-C in the heart [51].  Mice lacking cMyBP-C (MyBP-C-/-) were viable and 
displayed well-developed sarcomeres indicating MyBP-C is not essential for 
myofibrillogenesis.  However, MyBP-C-/- mice exhibited profound concentric cardiac 
hypertrophy and impaired diastolic and systolic function in vivo [51].  The impaired heart 
function was somewhat surprising in light of several studies showing enhanced myocyte 
contractility following manipulations of MyBP-C.  For instance, disrupting the 
interactions between MyBP-C and S2 enhanced myocyte shortening [15] and increased 
Ca2+ sensitivity of force in skinned myocardial preparations [87, 185].  Consistent with 
these results, partial extraction of MyBP-C also increased Ca2+ sensitivity of force in 
skinned myocytes [69] and sped shortening velocity in skinned skeletal muscle fibers 
[68].  These results are all consistent with a model in which MyBP-C affects myosin head 
flexibility and position perhaps by serving as collar or a tether.  Removal of this 
collar/tether would increase myosin head flexibility and bring the head in closer 
proximity to actin, thereby enhancing the probability of cross-bridge formation. 
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The purpose of this study was to examine the effects of targeted deletion of 
cMyBP-C on contractile function in single skinned myocytes, working under the 
hypothesis that myocytes lacking MyBP-C would have faster loaded shortening 
velocities, greater power output, and increased force redevelopment rates all due to 
elevated cross-bridge interaction kinetics resulting from removal of myosin head 
constraints normally imposed by MyBP-C.     
METHODS 
Experimental Animals 
Homozygous cardiac MyBP-C knockout mice (cMyBP-C-/-) were generated as 
previously described in detail [51].  Briefly, exons 3 through 10 of the murine cMyBP-C 
gene were deleted from mouse genomic DNA by homologous recombination.  Properly 
targeted embryonic stem cells were injected into C57/B6 blastocysts and implanted into 
C57/B6 pseudopregnant mice.  Appropriate breeding resulted in homozygous MyBP-C 
null mice.  Animals were housed in groups of two to three and provided food and water 
ad libitum.  All procedures involving animal use were performed according to the Animal 
Care and Use Committees of the University of Wisconsin and University of Missouri.  
The animals were anesthetized by intraperitoneal injection of sodium pentobarbital and 
euthanasia by excision of the heart. 
Cardiac Myocyte Preparation 
Skinned cardiac myocyte preparations were obtained from mouse hearts using 
methods similar to those described previously for rats [60].  The compositions of relaxing 
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and activating solutions were as follows (in mmol/L, obtained from Sigma at highest 
possible purity): free Mg2+ 1, EGTA 7, MgATP 4, imidazole 20, and creatine phosphate 
14.5 (pH 7.0); various [Ca2+] between 10-4.5 (maximal Ca2+ activating solution) and 10-9 
(relaxing solution); and sufficient KCl to adjust ionic strength to 180 mmol/L [116].   A 
portion of cardiac myocytes were aliquoted and stored in ATP free relaxing solution 
containing phosphatase inhibitors (20 mmol/L NaF and 50 µg/ml microcystin LR) at –
70°C for autoradiographic analysis.  The experimental apparatus used for physiological 
measurements of single skinned myocytes has been described [60].  The dimensions of 
the myocyte preparations are included in Table 2.1. 
 
 
Table 2.1:  Summary of myocyte dimensions 
 
                         Length, µm Width, µm SL at pCa 4.5, µm 
Wildtype 132.8 ± 28.4 20.1 ± 2.3 2.31 ± 0.097 
MyBP-C-/- 123.8 ± 31.4 24.3 ± 4.3 2.28 ± 0.089 
Values are means ± S.D., SL = sarcomere length 
 
 
Force-velocity and power-load measurements 
The protocol for obtaining force-velocity and power-load measurements has been 
described in detail [99] and all measurements were done at 13±1°C.  The attached 
myocyte was first transferred in maximal Ca2+ activating solution and allowed to obtain a 
steady state force, after which a series of sub-steady state force clamps were applied to 
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determine isotonic shortening velocities.  The isotonic force was maintained using a 
servo system for 150-250 ms while the length change during this time was monitored.  
Following the force clamp, the myocyte was slackened to near zero force to estimate the 
relative load sustained during the isotonic shortening, after which the myocyte was re-
extended to its starting length.  Due to the short lengths of single myocyte preparations, 
the rapid slackening following isotonic shortening did not always yield a baseline force 
value, the result of which is an underestimation of peak force and, thus, of the relative 
force during loaded contractions.  In these cases, more accurate estimates of the relative 
force during isotonic shortening were obtained by interpolating between the peak forces 
in isometric contractions that were performed before and after every series of loaded 
contractions.  The myocytes were kept in maximal Ca2+ activating solution for 2-3 
minutes during which 10-20 force clamps were performed without significant loss of 
force.  If maximal force fell below 80% of the initial value while performing the force 
clamps, the myocyte was discarded and the data not included.  Force-velocity 
measurements also were obtained during half-maximal Ca2+ activations following the 
protocol above.  Hyperbolic force-velocity curves were fitted to the relative force-
velocity data using the Hill equation:   
(P + a) (V + b) = (P0 + a)b, 
where P is force during shortening at velocity V; Po is the isometric force; and a and b are 
constants with dimensions of force and velocity, respectively.  Power load curves were 
obtained by multiplying force by velocity at each load on the force-velocity curve.   
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Rate of force redevelopment 
 The kinetics of force development were obtained using a procedure similar to that 
previously described [104].  While in activating solution (either maximal or half-maximal 
Ca2+), the myocytes were slackened by ~15% of myocyte length to produce zero force 
and subsequently underwent a brief period of unloaded shortening.  The myocyte was 
then rapidly restretched to its initial pre-slack length.  The slack-restretch maneuver 
caused nearly complete dissociation of cross-bridges, and the subsequent tension 
redevelopment was due to reattachment of cross-bridges and their transition into force-
generating states.  Force redevelopment traces were fit by a single exponential function: 
F = Fmax(1 – exp(-ktrt)) + Fres, 
where F is tension at time t, Fmax is maximal tension, and ktr is the rate constant of tension 
redevelopment.  Fres represents any residual tension present immediately after the slack-
restretch maneuver. 
 
SDS-PAGE and Autoradiography 
 To determine the effects that deletion of MyBP-C had on baseline 
phosphorylation of cardiac troponin I, myofibrillar samples were incubated 30 minutes 
with the catalytic subunit of PKA (3-5 µg/mL, Sigma) in the presence of (γ-32P)-ATP (50 
µCi, NEN).  The reaction was terminated by addition of electrophoresis sample buffer 
and heating at 95°C for 3 minutes.  Equivalent protein loads were then separated by SDS-
PAGE, silver stained, dried overnight, and exposed to a Kodak phosphoimaging screen 
for visualization on a phosphoimager.  Individual radiolabeled protein bands were then 
excised from the gel and quantified using a scintillation counter (Packard 1900 TR).  
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Stoichiometric cTnI phosphate incorporation was calculated using the following 
equation: 
cpm cTnI/[TnI] * [Pi]/cpm total = [Pi]/[cTnI], 
where all concentrations are in moles and cpm is counts per minute.  Figure 2.1 shows 
that MyBP-C and cTnI were phosphorylated by PKA in wild-types, while only cTnI was 
phosphorylated in myofibrils from MyBP-C-/- mice.  Additionally, stoichiometric analysis 
indicated that PKA-induced phosphorylation of cTnI was similar between WT (0.96 ± 
0.14 mol Pi/mol cTnI) and MyBP-C-/- (0.97 ± 0.17 mol Pi/mol cTnI) cardiac myofibrils.  
Data and Statistical Analysis 
 Skinned myocyte preparation length traces, force-velocity curves, power-load 
curves, and rate constants of force redevelopment were analyzed as previously described 
[104, 105].  Student t tests were performed to determine significant differences between 
WT and MyBP-C-/- as well as between maximal Ca2+ and half-maximal Ca2+ 
measurements.  P<0.05 was chosen as signifying significance.  All values are expressed 
as means ± SD. 
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Figure 2.1
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Figure 2.1: Effect of MyBP-C ablation on PKA-induced phosphate incorporation. 
Silver stain (A) and autoradiogram (B) of cardiac myofibrils from MyBP-C-/- (lanes 1-5) 
and WT (lanes 6-10) mice.  Note the lack of phosphorylation of MyBP-C in MyBP-C-/- 
myofibrils.  Also, the absence of MyBP-C did not appear to alter cTnI phosphorylation 
levels.  PKA-induced phosphorylation of cTnI was similar between MyBP-C-/- (0.97 ± 
0.17 mol Pi/mol cTnI) and WT (0.96 ± 0.14 mol Pi/mol cTnI) cardiac myofibrils. 
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RESULTS 
 
Force-velocity and power-load curves were measured in MyBP-C-/- myocytes to 
assess the role of MyBP-C on work capacity of cardiac myocytes.  Maximal Ca2+ 
activated force was unaffected by the absence of MyBP-C (WT = 17.0 ± 7.2 kN m-2 vs. 
MyBP-C-/- = 20.5 ±4.5 kN m-2).  On the other hand, force-velocity relationships were 
markedly altered in myocytes lacking MyBP-C.  Deletion of MyBP-C shifted the force-
velocity relationship upwards such that shortening velocity was faster at nearly all 
relative loads (Figure 2.2).  The bottom panel of Figure 2.2 shows that power output 
(normalized to isometric force, i.e., normalized power output) was also greater at nearly 
all relative loads in MyBP-C-/- myocytes, with peak normalized power output 
significantly increased by 26% (WT = 0.15 ± 0.01 versus MyBP-C-/- = 0.19 ± 0.03 
P/Po*ML/sec (p<0.05)) (Table 2.2).  The mean shortening velocity at loads optimal for 
power output (Vopt) was 25% faster in MyBP-C-/- myocytes (WT = 0.45 ± 0.03 ML/s 
versus MyBP-C-/- = 0.56 ± 0.10 ML/s (p<0.05)) (Table 2.2).  
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Figure 2.2 
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Figure 2.2: Effect of MyBP-C ablation on loaded shortening during maximal Ca2+  
activation.  
 
Force-velocity (top) and power-load (bottom) curves from WT and MyBP-C-/- skinned 
cardiac myocytes during maximal Ca2+ activations.  Loaded shortening and power output 
significantly increased at intermediate loads in MyBP-C-/- myocytes during maximal Ca2+  
activation.  Data points are means ± S.D. 
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Overall, these results suggest that the absence of MyBP-C increased power output 
of single myocytes solely by increasing loaded shortening rates (rather than an increase in 
force generating capacity), which likely resulted from faster crossbridge cycling rates at 
each given load. 
 
 
 
Table 2.2: Maximal calcium activated force, velocity and peak power output in 
wildtype and MyBP-C-/- mouse skinned cardiac myocytes. 
 Wildtype MyBP-C-/- 
Maximum Force, kN*m-2 17.03 ± 7.22 20.48 ± 4.45 
Vmax, ML * s-1 1.29 ± 0.19 1.60 ± 0.36 
Fopt 0.348 ± 0.028 0.351 ± 0.026 
Vopt, ML * s-1 0.446 ± 0.033 0.559 ±0.103* 
Peak normalized power output, 
P/P0 * ML * s-1 
0.154 ± 0.011 0.194 ± 0.032* 
Values are means ± S.D., n = 6 for each.  Fopt indicates relative force at which power was 
optimal.  *Significant difference from wildtype; P<0.05 
 
 
 
 Because Ca2+ activation of cardiac myofilaments does not likely reach a 
maximum in vivo, we also examined the effects of MyBP-C ablation on force, velocity, 
and power output during half-maximal Ca2+ activations.  These results are shown in 
Figure 2.3 and summarized in Table 2.3.  The pCa solution that yielded half-maximal 
force was 5.77 ± 0.08 in wild type and 5.67 ± 0.08 in MyBP-C-/-, indicating a slight 
reduction in Ca2+ sensitivity to force in MyBP-C-/- myocytes, although this shift was not 
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statistically significant (p=0.06).  Half-maximal Ca2+ activation also yielded force-
velocity and power-load curves that were shifted to higher velocities and loads in MyBP-
C-/- myocytes as compared to WT myocytes.  Interestingly, this upward shift was greater 
than that seen during maximal Ca2+ activation.  Deletion of MyBP-C increased loaded 
shortening and power output at all relative loads, and increased peak normalized power 
output 46% (WT = 0.09 ± 0.03 wildtype versus MyBP-C-/- = 0.14 ± 0.02 P/Po*ML/sec) 
compared to 26% during maximal Ca2+ activation.  Likewise, Vopt was 42% faster (WT = 
0.25 ± 0.05 versus MyBP-C-/- = 0.36 ±0.10) at half-maximal Ca2+ activation, compared to 
25% during maximal Ca2+ activation.  Overall, these results indicate that removal of 
MyBP-C results in faster loaded crossbridge cycling, and that this effect is relatively 
greater at half-maximal Ca2+ activation than at maximal Ca2+ activation. 
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Figure 2.3: Effect of MyBP-C ablation on loaded shortening during half-maximal 
Ca2+ activation.  
 
Force-velocity (top) and power-load (bottom) curves from WT and MyBP-C-/- skinned 
cardiac myocytes during half-maximal Ca2+ activations.  Loaded shortening velocity and  
power output were significantly increased in MyBP-C-/- myocytes at all loads. 
Data points are mean ± S.D. 
 
 39
Table 2.3:  Half-Maximal calcium activated force, velocity and peak power output  
in wildtype and MyBP-C-/- mouse skinned cardiac myocytes 
 
 Wildtype MyBP-C-/- 
Maximum Force, kN*m-2 10.82 ± 6.32 10.51 ± 1.53 
Vmax, ML * s-1 0.687 ± 0.224 0.833 ± 0.252 
Fopt 0.377 ± 0.059 0.388 ± 0.057 
Vopt, ML * s-1 0.251 ± 0.049 0.356 ±0.098* 
Peak normalized power output, 
P/P0 * ML * s-1 
0.093 ± 0.017 0.135 ± 0.031* 
Values are means ± S.D.  n = 6 for each.  *Significant difference from wildtype; P<0.05 
 
 
 
 To further examine the effects of MyBP-C ablation on crossbridge turnover 
kinetics, the rate of force redevelopment was measured during maximal and half-maximal 
Ca2+ activations.  Results are summarized in Figure 2.4.  Deletion of MyBP-C did not 
alter the rate constant of force redevelopment (ktr) during maximal Ca2+ activations.  
However, ktr at half-maximal Ca2+ activation was significantly greater in MyB-C-/- 
myocytes compared to WT (see inset in Figure 2.4).  
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Figure 2.4: Effect of MyBP-C ablation on rates of force development.  
 
A. Force traces following a slack-restretch maneuver in WT and MyBP-C-/- myocytes. 
The rate of force redevelopment was significantly increased in MyBP-C-/- myocytes at 
half-maximal Ca2+ activations as compared to WT.  *P<0.05 for MyBP-C-/- half maximal 
Ca2+ activation vs. WT half-maximal Ca2+ activation.  B. Summary of rates of force  
redevelopment in WT and MyBP-C-/- skinned cardiac myocytes during maximal (left) 
and half-maximal (right) Ca2+ activations. 
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DISCUSSION 
 
We examined the effects of targeted MyBP-C ablation on the functional 
properties of mouse skinned cardiac myocytes.  Deletion of MyBP-C significantly 
increased loaded shortening and power output during both maximal and half-maximal 
Ca2+ activation, as well as yielded faster rates of force redevelopment at half-maximal 
Ca2+ activation.  These increases in contractile function imply faster cross-bridge cycling 
rates under load in myocytes lacking MyBP-C. 
 
Function of MyBP-C on myocyte contraction  
 
Various functions have been suggested for MyBP-C, including a role in the 
assembly and structural support of the thick filament, and serving as a regulator of 
crossbridge movement.  Studies of the binding of MyBP-C to myosin have revealed 
MyBP-C binding sites on both light meromyosin (LMM) and the S2 subfragment of 
myosin, but not on the S1 subfragment [113, 114, 162].  The strong affinity of MyBP-C 
for LMM suggests a structural role for MyBP-C in the assembly and stabilization of the 
thick filament; however, MyBP-C does not appear to be necessary in vivo for assembly of 
highly organized myofibrils, which were observed in MyBP-C-/- mice [51].  MyBP-C 
also binds actin and regulated thin filaments (actin plus troponin-tropomyosin complex) 
in solution, and the latter is Ca2+ dependent [111, 113].  As the length of the MyBP-C 
molecule is sufficient to simultaneously contact both the thick and thin filaments in the 
intact filament lattice, an interaction between MyBP-C and actin in myofibrils is possible.  
In fact, MyBP-C has been observed to alter actin-activated myosin ATPase in solution 
 42
[112], an effect that varies depending on the ionic strength and molar ratio of actin and 
myosin, suggesting MyBP-C may facilitate positioning myosin and actin for interaction. 
 
The binding of MyBP-C to S-2 and actin suggests that MyBP-C is involved in 
regulating the contractile process and hypotheses regarding its possible regulatory 
function have been investigated using both cardiac myocytes and skeletal muscle fibers.  
Along these lines, the incorporation of soluble S2 myosin into intact cardiac myocytes 
[15], the addition of the N-terminal MyBP-C motif into skinned skeletal muscle fibers 
[87], and knock-in expression of a shortened N-terminal domain of cMyBP-C [185] have 
all been shown to increase Ca2+ sensitivity of force.  These results are consistent with the 
idea that the N-terminal domain of endogenous cMyBP-C constrains the flexibility and 
position of the myosin head via its interaction with S2.  Also consistent with this idea is 
the finding that extraction of 60-70% of endogenous MyBP-C in skinned cardiac 
myocytes and skeletal muscle fibers resulted in reversible increases in isometric tension 
at submaximal Ca2+ concentrations and a decrease in the apparent cooperativity of Ca2+-
dependent force development [69].  Based on these results, a model was proposed in 
which MyBP-C modulates the range of movement of myosin crossbridges, perhaps by 
tethering the crossbridges to the thick filament backbone, so that following MyBP-C 
extraction crossbridges are less constrained and the probability of myosin binding to actin 
is increased [69].  This model is consistent with a more recently proposed model in which 
three MyBP-C molecules interact to form a collar around the backbone of the thick 
filament, with projections from this collar able to interact with S2 [110]. 
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 MyBP-C also was shown to modify the apparent kinetics of cross-bridge 
interaction during muscle shortening [68], in that partial extraction of MyBP-C sped 
maximum shortening velocity (Vo) of fast skeletal muscle fibers at low levels of Ca2+ 
activation.  In control fibers at low levels of activation, the time course of unloaded 
shortening is normally biphasic, i.e., an initial phase of high velocity shortening is 
followed by low-velocity shortening.  The slowing of Vo as shortening proceeds is 
thought to result from an activation-dependent internal load that arises once there is a 
given amount of active shortening [117].  Partial extraction of MyBP-C reversibly 
increased Vo in the low velocity phase of unloaded shortening but had no effect on the 
high velocity phase.  One interpretation of this result is that at low levels of activation, 
MyBP-C gives rise to an internal load by simultaneously binding actin and myosin.  An 
alternative hypothesis is consistent with the model mentioned above (as proposed by 
Hofmann, et al. [68, 69]), whereby MyBP-C tethers the myosin head to the thick filament 
backbone, such that at low levels of Ca2+ when the rate of cross-bridge detachment is 
slow, cross-bridges give rise to an internal load once their useful working stroke is 
completed.  A similar hypothesis could arise from the trimeric collar model proposed by 
Moolman-Smook, et al. [110] in which the MyBP-C C-terminal collar restricts cross-
bridge formation while the N-terminal end is free to interact with S-2 and/or actin.  A 
prediction from these models is that both loaded shortening velocity and force 
redevelopment rates will be increased if extraction of MyBP-C is complete and thus the 
tether point or collar is removed.  This idea was addressed in this study using cardiac 
myocytes from MyBP-C-null mice and, indeed, both loaded shortening and force 
development rates were increased in MyBP-C-/- myocytes and these effects were greater 
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during half-maximal Ca2+ activation.  These results are consistent with the idea that 
MyBP-C constrains interactions of myosin heads with actin, as well as contributes an 
internal load that tends to reduce shortening velocity.  These results also agree with the 
idea that phosphorylation of cMyBP-C relieves constraint of the myosin head [181] as 
phosphorylation of cMyBP-C by cAMP dependent protein kinase A has been correlated 
with both faster force redevelopment in mouse skinned myocardium [135] and faster 
loaded shortening in rat skinned cardiac myocytes [61].  Interestingly, we saw 
significantly increased power output in single myocytes lacking MyBP-C despite MyBP-
C-/- myocardium containing increased amount of β-MyHC as seen by Harris et al. [51].   
β-MyHC is known to result in decreased power output in rat skinned cardiac myocytes 
[60] even if its quantity is small [59].  Because the upregulation of β-MyHC would likely 
depress the work capacity of single myocytes, the observed increase in power output may 
actually be an underestimation of what would be observed if MyBP-C ablation could be 
studied in myocytes containing 100% α-MyHC. 
  
There are, however, two predictions based on the above models that have not 
been borne out experimentally.  First, Ca2+ sensitivity of force was predicted to increase 
because both competitive inhibition of S2 binding by MyBP-C [87] and partial MyBP-C 
extraction [69] increased Ca2+ sensitivity.  It is reasonable to predict that if removal of 
MyBP-C reduces S1 constraints, more cross-bridges would be able to interact with the 
thin filaments, which in turn would cooperatively activate additional regulatory units and 
result in more force at a given [Ca2+].  However, ablation of MyBP-C was found to 
decrease Ca2+ sensitivity [51] and our current results are in agreement with this finding 
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because MyBP-C-/- myocytes required a slightly higher Ca2+ concentration to reach a 
force value that was half-maximal, although this difference was not considered 
significant (see results).  This unexpected finding may be accounted for by the fact that 
previous experiments in which MyBP-C was chemically extracted resulted in only partial 
relief of the constraint of myosin heads by MyBP-C.  As mentioned, previous studies that 
utilized N-terminal truncations [185], C-terminal truncations [188, 189], MyBP-C 
extraction [68, 69], and addition of phosphorylatable MyBP-C motif to skeletal muscle 
[87], all maintained at least some intact portions of MyBP-C, which may be involved in 
mediating mechanical interactions between myosin and actin.  For example, Witt et al., 
[185] produced an N-terminally shortened MyBP-C, which led to increased Ca2+ 
sensitivity.  In that instance, the carboxy terminal end was unaffected and thus able to 
normally interact with the rod portion of myosin.  Also, the increased Ca2+ sensitivity 
seen following MyBP-C extraction [69] occurred with many MyBP-C molecules still 
bound to S2, the myosin rod, and titin.  Interestingly, Yang et al., [188, 189] developed 
two different mouse models with a C-terminal truncation that also exhibited increased 
Ca2+ sensitivity of force.  Thus, it appears that both the N-terminal and C-terminal ends 
of MyBP-C exert separate regulatory effects and that complete deletion of MyBP-C 
yields an effect opposite to C-terminal or N-terminal deletions at least with regard to Ca2+ 
sensitivity of force.  A second possibility to explain the discrepancy between the expected 
and actual results is that some studies involved acute modifications of MyBP-C content 
while others, including this one, involved chronic changes.  For instance, our knockout 
model completely lacks MyBP-C from the onset of myocardial development.  Thus, some 
type of chronic compensatory changes in the myofilaments may account for the 
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unexpected decrease in Ca2+ sensitivity.  However, the decreased Ca2+ sensitivity does 
not appear to be due to increased baseline phosphorylation of cardiac troponin I because 
stoichiometric analysis indicated no significant difference in PKA-dependent phosphate 
incorporation between MyBP-C-/- and wildtype myofibrils (Figure 2.1).  Another possible 
explanation for reduced Ca2+ sensitivity is that Ca2+ affinity of TnC is reduced in MyBP-
C-/- myocardium due to changes in the normal feedback by which strongly bound cross-
bridges increase the binding affinity of TnC for Ca2+. [66]  For instance, the loss of the 
normal constraint of S1 by MyBP-C [110] would perhaps yield more flexible and 
compliant myosin cross-bridges, which could result in less developed force per cross-
bridge.  Reducing the force per cross-bridge may adversely affect the normal allosteric 
changes induced by cross-bridges on the thin filament that tend to enhance Ca2+ and/or 
cross-bridge binding. 
 
 
 Another apparent contradiction between the present results and literature reports 
is the finding that loaded shortening, power output, and force development rates were 
increased in MyBP-C-/- myocytes whereas MyBP-C-/- hearts demonstrate decreased 
contractile function in vivo.  This does not appear to be due to intercellular connections in 
some myocytes as control experiments yielded qualitatively similar differences between 
multi-cellular preparations from WT and MyBP-/- mice (data not shown).  It is possible 
that temperature differences between in vitro and in vivo measurements or some type of 
compensatory changes in myofibrillar proteins may contribute to these differences.  An 
alternative mechanism is compensated hemodynamic loads in MyBP-C-/- mice.  For 
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instance, when Calaghan et al., [15] introduced exogenous S2 into rat ventricular 
myocytes to compete with endogenous MyBP-C, skinned myocytes exhibited a 30% 
increase in contractility, but also an increase in the time to half-relaxation.  This is 
consistent with the finding that isovolumic relaxation is prolonged in MyBP-C-/- mouse 
hearts [51].  Slowed relaxation rates would lead to reduced filling time and decrease the 
end diastolic volume, which would depress systolic performance in accordance with the 
Frank-Starling relationship.  Prolonged relaxation is consistent with a model in which 
ablation of MyBP-C reduces structural constraint on myosin heads, allowing myosin 
heads to move closer on average to actin binding sites, and thereby increasing the 
probability of cross-bridge binding, delaying inactivation of thin filaments and 
prolonging relaxation.  Another possible explanation for prolonged relaxation in MyBP-
C-/- hearts in vivo is that there are compensatory alterations in [Ca2+]i handling, but this 
remains to be investigated.   
 
Overall, we found that complete removal of cMyBP-C led to faster loaded 
shortening and force development rates in mouse skinned cardiac myocytes.  Our results 
are consistent with a model whereby MyBP-C acts to constrain actin-myosin interaction, 
which limits loaded shortening velocity and ultimately power output.    
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Chapter 3:  SARCOMERE LENGTH DEPENDENCE OF RAT SKINNED 
CARDIAC MYOCYTE MECHANICAL PROPERTIES: 
DEPENDENCE ON MYOSIN HEAVY CHAIN ISOFORM 
 
 
 
ABSTRACT 
 
We investigated the effects of sarcomere length (SL) on Ca2+-sensitivity of force, 
rate of force development, and sarcomeric loaded shortening velocity and power output in 
rat skinned cardiac myocytes containing either α-myosin heavy chain (α-MyHC) or β-
MyHC at 12 ± 1°C.  Decreasing SL from 2.3 µm to 2.0 µm decreased submaximal 
isometric force ~40% in both α-MyHC and β-MyHC myocytes.  Peak absolute power 
output, however, decreased 55% in α-MyHC myocytes during submaximal Ca2+ activation, 
whereas β-MyHC myocytes exhibited a more pronounced decrease of ~70% between long 
and short SL.  Furthermore, peak power output was decreased about twice as much in β-
MyHC as in α-MyHC myocytes (41% vs. 20%) after normalizing for the fall in isometric 
force from long to short SL.  To determine whether the fall in normalized power with 
decreased SL was due to the lower force levels (and presumably reduced thin filament 
activation levels) we increased Ca2+ at short SL to match force at long SL.  Surprisingly, 
this led to a 32% greater peak normalized power output at short SL compared to long SL in 
α-MyHC myocytes.  However, in β-MyHC myocytes peak normalized power output 
remained depressed at short SL as compared to long SL when force levels were matched.  
This implies that lower thin filament activation levels are important in governing the fall in 
power with reduced SL as it appears that loaded crossbridge cycling is actually faster at 
short SL, at least in α-MyHC myocytes.   
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The role that interfilament spacing plays in determining SL dependence of power 
was tested by adding the osmotic polymer dextran to compress myocytes at short SL.  
Addition of 2% dextran at short SL decreased myocyte width, likely decreased the lateral 
spacing between the thick and thin filaments, and increased force to levels obtained at 
long SL.  Peak normalized power output at short SL with dextran was increased to values 
greater than at long SL in both α- MyHC and β-MyHC myocytes.  This suggests that the 
greater lattice spacing at short SL tends to mitigate optimal crossbridge binding and 
reduce power.  The effect of α-MyHC and β-MyHC content on Ca2+ sensitivity of force 
was determined following incubation with PKA to normalize for potential differences in 
basal myofibrillar protein phosphorylation.  There was no difference in maximal 
isometric force between α-MyHC and β-MyHC myocytes but Ca2+ sensitivity of force 
was slightly greater in β-MyHC myocytes at both long and short SL.  A decrease in SL 
from 2.3 µm to 2.0 µm decreased Ca2+ sensitivity of force similarly in both α-MyHC and 
β-MyHC myocytes.  The rate constant of force development (ktr) also was measured and 
was not different between long and short SL in α-MyHC myocytes but was increased at 
short SL in β-MyHC myocytes.  At short SL with matched levels of activation with either 
dextran or [Ca2+], ktr was increased versus long SL in both α-MyHC and β-MyHC 
myocytes.  These results are consistent with the idea that an intrinsic length component 
increases crossbridge kinetics at short SL. 
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INTRODUCTION 
 
Increased end-diastolic volume has been shown to increase stroke volume in 
isolated heart preparations [136] and in intact animals [11], a relationship commonly 
referred to as the Frank-Starling relationship.  The underlying cellular mechanism of this 
relationship is thought to involve, at least in part, an increase in the tension generating 
capacity of individual myocytes with increased sarcomere length (SL) in accordance with 
the length-tension relationship of striated muscle [29, 43, 160].  This is especially steep in 
cardiac muscle at submaximal Ca2+ activations [79], which myocytes are thought to 
encounter in vivo.  During ejection, however, the ventricles are contracting against an 
afterload and are therefore undergoing loaded shortening (i.e., performing work).  
Despite the physiological and pathophysiological importance of the Frank-Starling 
relationship, few experiments have attempted to determine the effects of SL on loaded 
shortening in cardiac myocytes.  We tested the hypothesis that cardiac myocyte power 
output is tightly regulated by initial SL, which was examined by measuring load 
dependence of shortening velocity and power output at two initial sarcomere lengths (i.e., 
2.3 µm and 2.0 µm). 
 
 Numerous studies suggest a primary cause of length dependence of myocardial 
function arises from a change in myofilament Ca2+ sensitivity of force [4, 64], brought 
about, in part, by a change in interfilament lattice spacing  (for review see [34]).  As a 
myocyte is shortened, the lateral spacing between the thick and thin filament is increased 
[74, 137, 148, 187], which likely decreases the probability of myosin binding to actin and 
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yields fewer force-generating crossbridges that activate the thin filament.  This study 
additionally tested the hypothesis that SL dependence of power output results from 
changes in thin filament activation levels and/or lattice spacing   We measured loaded 
shortening velocity and power output at short SL at the same force (by addition of 
activating Ca2+) or the same force and myocyte width (by addition of 2% dextran) to 
those at long SL. 
 
 Myosin heavy chain (MyHC) isoform content also has been shown to be a key 
regulator of loaded shortening and power output [60, 85].  No studies, however, have 
addressed how MyHC affects SL dependence of power output in spite of the observation 
that several disease states in rodents and humans have been shown to up-regulate β-
MyHC and down-regulate α-MyHC [25, 109].  Increased β-MyHC has negative 
consequences for power [62, 85] but seems to increase the economy of contraction [152].  
Additionally, it has been shown that heart rate is inversely related to β-MyHC content 
[49].  Since a slower heart rate allows more filling time it may be that ventricles 
containing β-MyHC rely more on SL changes to modulate stroke volume than do 
ventricles with α-MyHC.  This is consistent with the finding that rat left ventricles that 
contained >70% β-MyHC exhibited steeper ventricular function curves than left ventricle 
that contained predominantly α-MyHC [31].  Therefore, we also tested the hypothesis 
that β-MyHC myocytes have increased SL dependence of power output compared to α-
MyHC myocytes. 
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 Additionally, we examined whether there are inherent differences between α-
MyHC and β-MyHC myocytes in the sarcomere length dependence of Ca2+ sensitivity of 
force and the rates of force development.  Experiments were designed to determine if 
changes in these parameters could explain potential variations in left ventricular function 
curves between α-MyHC and β-MyHC hearts. 
 
MATERIALS AND METHODS 
 
Experimental animals 
Male Sprague-Dawley rats (6 weeks old) were obtained from Harlan (Madison, 
WI), housed in groups of 2 or 3 and provided access to food and water ad libitum.  Rats 
were made hypothyroid by adding 6-propylthiouracil (PTU, 0.8 mg/mL) to the drinking 
water.  PTU treatment shifted cardiac MyHC isoform content from 100% α-MyHC to 
100% β-MyHC over a three week period.  Thyroidectomy, PTU (intraperitoneally or 
orally) administration, or the combination of thyroidectomy and PTU have been shown to 
alter MyHC isoform expression without altering the expression of other key myofilament 
proteins [32, 60, 107].  All procedures involving animal use were performed according to 
the Animal Care and Use Committee of the University of Missouri. 
 
Solutions 
The compositions of relaxing and activating solutions were as follows (in 
mmol/L, obtained from Sigma at highest possible purity): free Mg2+ 1, EGTA 7, MgATP 
4, imidazole 20, and creatine phosphate 14.5 (pH 7.0); specific [Ca2+] between 10-4.5 
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(maximal Ca2+ activating solution) and 10-9 (relaxing solution); and sufficient KCl to 
adjust ionic strength to 180 mmol/L.  Relaxing solution also contained 2 mM Pefabloc 
(Roche) and 0.25 mM leupeptin (Sigma) to inhibit proteases and preserve the integrity of 
the myocytes. 
 
Myocardial preparations 
Skinned cardiac myocytes were obtained by mechanical disruption of hearts from 
Sprague-Dawley rats as described previously [99].  Briefly, rats were anaesthetized by 
inhalation of isoflurane (20% v/v in olive oil), and their hearts were excised and rapidly 
placed in ice cold relaxing solution.  The left ventricle was separated from the right 
ventricle and dissected from the atria, cut into 2-3 mm pieces and further disrupted for 5 
seconds in a Waring blender.  The resulting suspension of cells was centrifuged for 105 
sec at 165 x g, after which the supernatant fluid was discarded.  The myocytes were 
skinned by suspending the cell pellet for 5 min in 0.3 % ultrapure Triton X-100 (Pierce 
Chemical Co.) in cold relaxing solution.  The skinned cells were washed twice with cold 
relaxing solution, suspended in 10 ml of relaxing solution and kept on ice.  One myocyte 
per heart was used.     
    
Experimental Apparatus  
 The experimental apparatus for physiological measurements of myocyte 
preparations was similar to one previously described in detail [116] and modified 
specifically for cardiac myocyte preparations [99].  Briefly, a myocyte was attached 
between a force transducer and high speed motor by gently placing the ends of the 
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myocyte into stainless steel troughs (25 gauge).  The ends of the myocyte were secured 
by overlaying a 0.5 mm long piece of 3-0 monofilament nylon suture (Ethicon, Inc.) onto 
each end of the myocyte, and then tying the suture into the troughs with two loops of 10-
0 monofilament suture (Ethicon, Inc.).  The attachment procedure was performed under a 
stereomicroscope (~100x magnification) using very fine tipped forceps.   
 
Prior to mechanical measurements the experimental apparatus was mounted on 
the stage of an inverted microscope (model IX-70, Olympus Instrument Co., Japan), 
which rested on a pneumatic anti-vibration table with a cut-off frequency of ~1 Hz.  
Force measurements were made using a capacitance-gauge transducer (Model 403-
sensitivity of 20 mV/mg plus a x10 amplifier and resonant frequency of 600 Hz; Aurora 
Scientific, Inc., Aurora, ON, Canada).  Length changes during mechanical measurements 
were introduced at one end of the preparation using a DC torque motor (model 308, 
Aurora Scientific, Inc.) driven by voltage commands from a personal computer via a 12-
bit D/A converter (AT-MIO-16E-1, National Instruments Corp., Austin, TX, USA).  
Force and length signals were digitized at 1 kHz using a 12-bit A/D converter and each 
was displayed and stored on a personal computer using custom software based on 
LabView for Windows (National Instruments Corp.).  Sarcomere length was monitored 
and recorded using IonOptix SarcLen system (IonOptix, Milton, MA), which used a fast 
fourier transform algorithm of the video image of the myocyte (Figure 3.1).  Figure 3.1A 
illustrates muscle length (top) and sarcomere length (middle) traces during a load clamp 
(bottom) at both long and short SL.  Figure 3.1B illustrates that muscle length and 
sarcomere length traces are closely matched over the entire range of relative loads.  
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Videomicroscopy was completed using a 40x objective (Olympus UWD 40) and 25x 
intermediate lenses.   
 
Force-velocity and power-load measurements 
The protocol to obtain force-velocity and power-load measurements has been described 
in detail [100] and all measurements were done at 12 ± 1°C.  An attached myocyte was 
first transferred into maximal Ca2+ activating solution (pCa 4.5) and allowed to obtain 
maximal steady-state isometric force.  It was then transferred to a submaximal Ca2+ 
activating solution and a series of sub-isometric force clamps were applied to determine 
isotonic shortening velocities.  The isotonic force was maintained using a servo system 
for 150-250 ms while muscle length and sarcomere length changes during this time were 
monitored.  Figure 3.1A illustrates a force clamp and corresponding muscle length and 
sarcomere length changes.  Following the force clamp, the myocyte was slackened to 
near zero force to estimate the relative load sustained during the isotonic shortening, after 
which the myocyte was re-extended to its starting length.  Due to the short lengths of the 
myocytes the rapid slackening following isotonic shortening did not always result in an 
accurate baseline force value and consequently resulted in an underestimation of peak 
force and, thus, of the relative force during loaded contractions.  In these cases, more 
accurate estimates of the relative forces during isotonic shortening were obtained by 
interpolating between the peak forces in isometric contractions that were performed 
before and after every series of loaded contractions.  The myocytes were kept in 
submaximal Ca2+ activating solution 2-4 minutes during which 10-20 force clamps were 
performed without significant loss of force.  If force fell below 80% of initial force, data  
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Figure 3.1 
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Figure 3.1: Muscle length, sarcomere length, and force traces of a submaximally 
Ca2+ activated cardiac myocyte. 
 
A. Examples of myocyte shortening (top) and sarcomere shortening (middle) at clamped 
force (bottom) at long and short sarcomere length during submaximal Ca2+ activations.  
Photomicrographs of Ca2+ activated myocyte at long and short sarcomere length are inset.  
B.  Force-velocity points generated from muscle length (ML) traces (closed circles) and 
sarcomere length traces (open circles) demonstrate that SL and ML are closely matched 
in our system. 
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from that myocyte were discarded.  Force-velocity measurements were obtained in this 
manner for all experimental conditions. 
 
Measurement of rate constant of force development   
 Measurement of tension development kinetics was accomplished by using a 
modification of [14] as previously described [104] and adjusted for cardiac myocytes.  
Briefly, a myocyte in activating solution was allowed to develop tension to plateau after 
which it was rapidly slacked by 15-20% of original myocyte length (L0) and held for 20 msec 
and then was rapidly restretched to a value slightly greater than L0 for 2 ms before it was 
returned to L0.  This slack-restretch maneuver caused dissociation of crossbridges, and thus 
tension redevelopment was due to reattachment of crossbridges to the thin filament and 
subsequent transition to force generating states.   
 
SDS-PAGE and silver staining  
 Following power output measurements the relative expression of MyHC was 
determined for each myocyte.  The myocyte was removed from the experimental apparatus 
and stored in 10 µl of SDS sample buffer at -80°C for subsequent SDS-PAGE analysis.  The 
gel electrophoresis procedure was similar to one previously described [60, 62].  The gels 
were prepared with 3.5% acrylamide in the stacking gel and 12% acrylamide in the resolving 
gel.  Myocyte proteins were separated at constant current (12 mA) for 8.5 hours.  The 
separated proteins were fixed in an acid-alcohol solution followed by glutaraldehyde.  MyHC 
isoforms were visualized by ultrasensitive silver staining and then gels were dried and stored 
between Mylar sheets (Figure 3.2).  The relative expression of each MyHC isoform was 
 58
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: MyHC separation using SDS-PAGE.   
 
Silver stained gel image of single cardiac myocytes using SDS-PAGE to specifically 
separate myosin heavy chains.  
59 
determined by using QuantiScan (Biosoft) software and an Epson scanner to measure the 
relative intensities and areas of each MyHC band.  MyHC content expressed as relative 
β-MyHC content is summarized in Table 3.1.      
 
Data analyses 
 
 Myocyte length traces, force-velocity curves, and power-load curves were 
analyzed as previously described [99].  Myocyte length and sarcomere length traces 
during loaded shortening were fit to a single decaying exponential equation:   
(1)                                                    L = Ae-kt + C 
where L is cell length at time t, A and C are constants with dimensions of length, and k is 
the rate constant of shortening (kshortening).  Velocity of shortening at any given time, t, 
was determined as the slope of the tangent to the fitted curve at that time point.  In this 
study velocities of shortening were calculated by extrapolation of the fitted curve to the 
onset of the force clamp (i.e., t = 0). 
 
   Hyperbolic force-velocity curves were fit to the relative force-velocity data using 
the Hill equation.[65]  
(2)                                          (P + a)(V + b) = (Po + a)b 
where P is force during shortening at velocity V; Po is the peak isometric force; and a and 
b are constants with dimensions of force and velocity, respectively.  Power-load curves 
were obtained by multiplying force x velocity at each load on the force-velocity curve 
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.The optimum force for mechanical power output (Fopt) was calculated using the equation 
[186]  
(3)                                                Fopt = (a2 + a·Po)1/2 - a 
Curve fitting was performed using a customized program written in Qbasic, as well as 
commercial software (Sigmaplot).   
 
The shape and mid-point (pCa50) of the tension-pCa relationship were calculated 
by Hill plot analyses of the data as previously described [158].  Linear fits to the tension 
data above and below 0.5 P0 were obtained by least-squares analysis using the equation: 
Log[Pr/(1-Pr)] – n(log[Ca2+] = pCa50, 
where Pr is tension expressed as a fraction of P0 and pCa50 is the Ca2+ concentration for 
half-maximal activation.  Mean tension-pCa data were displayed (Figure 3.6) using the 
equation: 
Pr = [Ca2+]n/(([Ca2+]50)n + [Ca2+]n), 
 where Pr is tension expressed as a fraction of P0, [Ca2+]50 is the Ca2+ concentration for 
half-maximal activation, and n is the Hill coefficient. 
 
 Tension redevelopment following slack-restretch maneuver was well fit by a 
single exponential equation: 
F = Fmax(1 – e-ktrt). 
where F is tension at time t, Fmax is maximal tension, and ktr is the rate constant of force 
development. 
 
 62
 Paired t tests were used to determine if SL significantly affected loaded 
shortening velocity, power, ktr or pCa50.  Student’s t test was used to test for differences 
in velocity, power, ktr or pCa50 between α-MyHC and β-MyHC myocytes.  One-way 
ANOVA was used to determine differences between long SL, short SL + matched force, 
and short SL + matched width groups, and a Student-Neuman-Keuls was performed as a 
post-hoc test to assess differences between group means.  In all cases, P < 0.05 was 
accepted as a significant difference.  Data are presented as means ± S.D.  n = the number 
of myocyte preparations. 
 
RESULTS 
Sarcomere length dependence of absolute and normalized power output in α-MyHC 
myocytes. 
 The sarcomere length dependence of loaded shortening was examined by 
characterizing force-velocity and power-load curves during submaximal Ca2+ activation 
at long (~2.3 µm) and short SL (~2.0 µm) in α-MyHC myocytes (n = 12).  Figure 3.3A 
illustrates the sarcomere length dependence of loaded shortening and absolute power 
output from skinned cardiac myocytes containing α-MyHC.  At short SL as compared to 
long SL, isometric force was decreased 40% while peak absolute power fell 55%, 
indicating power fell by mechanisms other than just decreased isometric force.  This can 
be more clearly seen in force-velocity and power-load curves after normalization to 
isometric force (Figure 3.3B.)  The normalized force-velocity curve shows that loaded 
shortening velocity was decreased at short versus long SL for given relative loads less  
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Figure 3.3 
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Figure 3.3: Sarcomere length dependence of isotonic shortening velocity and power 
output in α-MyHC cardiac myocytes.   
 
A. Absolute force-velocity (top) and power output (bottom) curves from myocytes 
expressing α-MyHC at long (closed circles) and short (open circles) sarcomere length.  B.  
Normalized force-velocity (top) and power output (bottom) curves from myocytes 
expressing α-MyHC at long (closed circles) and short (open circles) sarcomere length as 
labeled.  At short SL isometric force was decreased, which caused a fall in absolute 
power output.  However, the decrease in absolute power output was greater than the 
decrease in force, which indicates slower shortening velocities for a given relative load as 
seen in the normalized force-velocity and power load curves.  Data points are means ± 
S.D., force-velocity curves fit by Hill equation as described in Methods, power-load 
curves fit by eye. 
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than ~40% of isometric force, which resulted in a 20% decrease in peak normalized 
power output.  Interestingly, shortening velocity did not appear to be slower at short SL 
at loads greater than 40% of isometric force.  The mechanical properties of α-MyHC 
myocytes are presented in Table 3.2. 
 
Sarcomere length dependence of absolute and normalized power output in β-MyHC 
myocytes. 
 The sarcomere length dependence of loaded shortening and power output were 
also examined at long and short SL in β-MyHC myocytes (n = 11).  Figure 3.4A 
illustrates the sarcomere length dependence of absolute loaded shortening and power 
output in β-MyHC myocytes.  As with α-MyHC myocytes, isometric force was 
decreased at short SL, which led to a decrease in absolute power.  However, the fall in 
absolute power was even more pronounced in β-MyHC myocytes.  Isometric force was 
decreased 41% while peak absolute power fell nearly 70%.  After normalization of the 
curves to isometric force (Figure 3.4B), loaded shortening velocity was clearly decreased 
at short versus long SL for a given relative load less than ~50% of isometric force; this 
resulted in a 41% decrease in peak normalized power output in β-MyHC myocytes.  Thus 
β-MyHC myocytes are more sensitive to changes in SL at a given [Ca2+] than are α-
MyHC myocytes.   
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Figure 3.4 
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Figure 3.4: Sarcomere length dependence of isotonic shortening velocity and power 
output in β-MyHC cardiac myocytes.    
 
A. Absolute force-velocity (top) and power output (bottom) curves from myocytes 
expressing β-MyHC at long (closed circles) and short (open circles) sarcomere length.  B.  
Normalized force-velocity (top) and power output (bottom) curves from myocytes 
expressing β-MyHC at long (closed circles) and short (open circles) sarcomere length as 
labeled.  As in α-MyHC myocytes, isometric force and absolute power output were 
decreased at short SL, but the decrease in shortening velocity and power was even more 
pronounced in β-MyHC myocytes as indicated by the greater fall in peak normalized 
power output.  Data points are means ± S.D., force-velocity curves fit by Hill equation as 
described in Methods, power-load curves fit by eye. 
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 However, similar to α-MyHC, shortening velocities at short SL did not appear to be 
slower at loads greater than 50% of isometric force.  The mechanical properties of β-
MyHC myocytes are presented in Table 3.3. 
 
Effects of Ca2+ activation on normalized loaded shortening and power output 
 It was previously shown that shortening SL decreases Ca2+ sensitivity of force 
[64, 79] and loaded shortening velocity is tightly regulated by force and thin filament 
activation levels [75, 99, 103].  Thus, a possible mechanism underlying the decreases in 
loaded shortening velocity and power output at short SL could be the associated decrease 
in force and thin filament activation levels.  To probe this mechanism, force and, 
presumably the thin filament activation levels, at short SL were matched to those seen at 
long SL by increasing the Ca2+ concentration.  Figure 3.5A illustrates that matching force 
at long and short SL actually led to faster loaded shortening velocities and 32% greater 
peak normalized power output at short SL (0.18 ± 0.02 P/P0 • um • sarc-1 • s-1) than 
observed at long SL (0.14 ± 0.03 P/P0 • um • sarc-1 • s-1) in α-MyHC myocytes.  This 
implies that there is a myofibrillar mechanism that leads to faster loaded crossbridge 
kinetics at shorter SL in α-MyHC myocytes.  In β-MyHC myocytes normalization of 
force at short SL slightly sped loaded shortening and increased power output as would be 
expected with the increase in force but, in contrast to α-MyHC myocytes, peak 
normalized power output was decreased 28% at short SL (0.07 ± 0.02 P/P0 • um • sarc-1 • 
s-1) compared to long SL (0.09 ± 0.02 P/P0 • um • sarc-1 • s-1) (Figure 3.5B). 
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  Effects of osmotic compression on normalized loaded shortening and power output 
The effects of changes in lattice spacing that occur with changes in sarcomere 
length were examined by adding the osmotic polymer dextran to activating solution at 
short SL.  Dextran osmotically decreased myocyte width by decreasing cell volume.  In 
this study, 2% dextran at short SL was sufficient to decrease the width of the myocyte 
and to increase force to match both the width and force seen at long SL in α-MyHC and 
β-MyHC myocytes.  In α-MyHC myocytes at short SL, 2% dextran increased loaded 
shortening velocity at nearly all relative loads and increased peak normalized power 
output 59% (0.22 ± 0.05 P/P0 • um • sarc-1 • s-1) compared to long SL (Figure 3.5A),  
This was 21% greater than at short SL with matched force.  This further implicates a 
myofibrillar mechanism that leads to faster loaded crossbridge kinetics at short SL in α-
MyHC myocytes.  Interestingly, addition of 2% dextran to β-MyHC myocytes increased 
loaded shortening velocity at nearly all relative loads, and peak normalized power output 
was increased 52% (0.14 ± 0.06 P/P0 • um • sarc-1 • s-1) above that at long SL (Figure 
3.5B); this was more than double that seen at short SL with matched force.  Therefore, β-
MyHC myocytes also appeared to have a myofibrillar mechanism that led to faster loaded 
crossbridge kinetics at shorter SL but, in contrast to α-MyHC myocytes where power 
increased at short SL with both matched force via increased calcium and matched width 
via dextran, power output in β-MyHC myocytes only increased with matched width via 
dextran.   
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Figure 3.5 
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Figure 3.5:  Sarcomere length dependence of isotonic shortening velocity and power 
output in α-MyHC and β-MyHC cardiac myocytes with matched activation levels.   
 
A. Normalized force-velocity (top) and power output (bottom) curves from myocytes 
expressing α-MyHC at long SL (closed circles), short SL with increased Ca2+ to match 
force (closed triangles), and short SL + Dextran (open triangles).  Loaded shortening 
velocity and peak normalized power output are elevated at short SL to levels greater than 
at long SL when activation levels are matched by either increased [Ca2+] or by osmotic 
compression in α-MyHC myocytes.  B.  Normalized force-velocity (top) and power 
output (bottom) curves from myocytes expressing β-MyHC at long SL (closed circles), 
short SL with increased Ca2+ to match force (closed triangles), and short SL + Dextran 
(open triangles).  In β-MyHC myocytes, matched activation by osmotic compression 
sped loaded shortening and increased normalized power output to levels greater than at 
long SL while matched activation through increased [Ca2+] only sped loaded shortening 
to levels equivalent to that seen at long SL. Data points are means ± S.D., force-velocity 
curves fit by Hill equation as described in Methods, power-load curves fit by eye. 
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Thus, β-MyHC myocytes appeared to be more responsive to changes in 
interfilament spacing and, as a result, the increase in lattice spacing associated with short 
SL was, in part, responsible for the decrease in loaded shortening velocity and power 
even at matched Ca2+ activation levels.  This also is consistent with the observed 
increased SL dependence of loaded shortening in β-MyHC myocytes. 
 
 
Role of myosin heavy chain in determining sarcomere length dependence of Ca2+ 
sensitivity to force 
 MyHC dependence of Ca2+ sensitivity to force was determined with tension-pCa 
curves generated using skinned cardiac myocytes containing either α-MyHC or β-MyHC 
that had been exposed to the catalytic subunit of PKA.  PKA was used to normalize 
PKA-induced phosphorylation levels in myofibrillar proteins myosin binding protein-C 
(MyBP-C) and troponin I (TnI).  Figure 3.6 illustrates the tension-pCa relationships of α-
MyHC and β-MyHC myocytes at long (2.3 µm) and short (2.0 µm) SL.  There was a 
statistical difference in pCa50 of ~0.1 pCa units at both long SL and short SL between α-
MyHC and β-MyHC myocytes (Table 3.1).  The shifts in pCa50 (∆pCa50) from long SL to 
short SL were not different between α-MyHC and β-MyHC myocytes and were 0.09 ± 
.02 and 0.08 ± 0.01, respectively.   
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Figure 3.6 
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Figure 3.6: Tension-pCa relationship following PKA treatment in α-MyHC and β-
MyHC myocytes. 
 
Myocytes containing α-MyHC were more sensitive to Ca2+ at long SL (closed circles) 
than at short SL (closed triangles) following PKA treatment.  Myocytes containing β-
MyHC also were more sensitive to Ca2+ at long (open circles) than at short SL (open 
triangles).  There was a statistical difference in Ca2+ sensitivity at both long and short SL 
between α-MyHC and β-MyHC.  Data points are means ± S.D. 
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Effects of sarcomere length, osmotic compression, and Ca2+ activation on force 
development 
 In α-MyHC myocytes, there was no difference in the rate constants of force 
development (ktr) between long SL (ktr = 2.38 ± 0.56 s-1) and short SL (ktr = 2.52 ± 0.69 s-
1) (Figure 3.7A).  At short SL, however, increasing [Ca2+] to match force activation levels 
at long SL (ktr = 4.63 ± 0.26 s-1) or adding 2% dextran to match myocyte width (ktr = 4.76 
± 0.18 s-1) led to significantly greater rates of force redevelopment compared to long or 
short SL alone (Figure 3.7C).  This strengthens the implication that crossbridge kinetics 
increased at short SL in α-MyHC myocytes.  Interestingly, β-MyHC myocytes exhibited 
faster rates of force development at short SL (ktr = 1.18 ± 0.35 s-1), short SL with matched 
force (ktr = 2.15 ± 0.30 s-1), and short SL with matched width (ktr = 2.39 ± 0.74 s-1), 
compared to long SL (ktr = 1.79 ± 0.40 s-1) (Figures 3.7B and 3.7D).  Moreover, force 
development rates were not significantly faster at short SL with matched force versus 
short SL alone, but were faster at short SL with matched width in β-MyHC myocytes.  
Again, this implies increased crossbridge kinetics at short SL but β-MyHC myocytes 
appear to be more affected by lattice spacing than α-MyHC myocytes, vis-à-vis the 
change in myocyte width. 
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 Figure 3.7 
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Figure 3.7: Sarcomere length dependence of rate constant of force development in 
α-MyHC and β-MyHC cardiac myocytes.   
 
A. Normalized force traces fit with a rising exponential to calculate the rate constant of 
force development from an α-MyHC myocyte at long (upper solid line) and short SL 
(lower dashed line).  B.  Normalized force traces fit with a rising exponential from a β-
MyHC myocyte at long (lower solid line) and short SL (upper dashed line).  C.  Rate 
constants of force development for α-MyHC myocytes at long SL, short SL, short SL 
with matched force, and short SL with matched width.  D.  Rate constants of force 
development for β-MyHC myocytes at long SL, short SL, short SL with matched force, 
and short SL with matched width.  * Significantly different from long SL (p<0.05).  † 
Significantly different from short SL (p<0.05).  Data are means ± S.D. 
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DISCUSSION 
 
The results of these experiments show that decreasing sarcomere length in rat 
skinned cardiac myocyte preparations significantly decreased both absolute and 
normalized loaded shortening velocity and power output, and that this SL dependent 
decrease is more pronounced in myocytes containing β-MyHC.  Additionally, when force 
was matched at short SL to that seen at long SL by increased calcium, loaded shortening 
velocity and power were increased above that seen at long SL in α-MyHC myocytes but 
not β-MyHC myocytes.  When myocyte width was matched at short SL to that seen at 
long SL loaded shortening velocity and power were increased above that seen at long SL 
in both α-MyHC and β-MyHC myocytes.  There was no difference in maximal force 
generating capacity between α-MyHC and β-MyHC but β-MyHC myocyte force was 
more sensitive to calcium than α-MyHC myocytes at both long and short SL following 
incubation with PKA.  Also, faster rates of force development were observed at short SL 
than at long SL in β-MyHC myocytes, whereas α-MyHC myocytes rate constants of 
force development between long and short SL were not different.  The results of these 
experiments indicate that crossbridge kinetics are increased at short SL in both α-MyHC 
and β-MyHC myocytes and that there are MyHC specific differences in responsiveness to 
SL changes. 
The cellular basis for the Frank-Starling relationship arises from beat-to-beat 
changes in diastolic myocyte length, and thus changes in myocyte sarcomere length.  
Increasing sarcomere length within the working range of the myocardium (~1.9 µm to 2.3 
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µm) [45, 47, 140] increases force generating capacity due , in part, to more optimal 
overlap of the thick and thin filaments [43], increased activator Ca2+ released from the 
sarcoplasmic reticulum [5], and enhanced myofibrillar sensitivity to Ca2+ [5, 66, 79, 101].  
A study by Sonnenblick found that increasing initial muscle length increased force 
without an apparent change in the maximal velocity of shortening (Vmax), as extrapolated 
from force-velocity curves [160].  However, a study utilizing lightly loaded ferret 
papillary muscle showed that shortening velocity of a well-defined central muscle 
segment declined with decreased muscle segment lengths [97].  Also, a more recent study 
showed that V0 of sarcomere shortening was increased in proportion to SL between 1.9 
µm and 2.3 µm at submaximal Ca2+ activation in rat cardiac trabeculae [24].  These 
studies imply a SL-dependent effect of cardiac muscle shortening.  We sought to directly 
address this hypothesis by measuring sarcomere shortening velocity in skinned cardiac 
myocytes that allow control of Ca2+ activation levels and that lack extracellular 
viscoelastic elements that may affect shortening.  The use of rats also allowed 
manipulation of MyHC content via administration of propylthiouracil, which binds 
circulating thyroid hormone and induces a shift in the heart from α-MyHC to β-MyHC.  
It is important to determine the difference in SL responsiveness between α-MyHC and β-
MyHC because there are changes in MyHC expression in response to a number of 
physiological and pathophysiological conditions, including up-regulation of β-MyHC in 
rodents in response to diabetes [25, 38] and pressure overload [90, 92, 95] and in failing 
human myocardium [109].  The latter carries clinical relevance, as there are a number of 
studies that have demonstrated the Frank-Starling mechanism is compromised in animal 
models of heart failure [81, 150] and in human failing myocardium [72, 157]. 
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Sarcomere length dependence of loaded shortening and power output 
 This study found a sarcomere length dependence of absolute loaded shortening 
velocity and power output in both α-MyHC and β-MyHC skinned cardiac myocytes, but 
the effect of sarcomere length was more pronounced in β-MyHC myocytes.  Much of the 
sarcomere length dependence arose from changes in isometric force, but relative force 
curves between long and short SL still showed SL dependence of loaded shortening 
velocity and power output, especially at loads around 30% of isometric force where the 
heart is thought to work in vivo.  A plausible reason for slower shortening velocity at 
short SL is increased cooperative inactivation of the thin filament during myocyte 
shortening [75, 99].  For instance, at shorter sarcomere length there is decreased Ca2+ 
sensitivity of force arising at least in part from fewer crossbridges.  The reduction in 
shortening velocity could then arise from more cooperative inactivation of the thin 
filament at the onset of and throughout the force clamp, leaving fewer crossbridges to 
bear a fixed relative load at short SL.  This is supported by our previous work [99] that 
showed decreasing activator Ca2+ to yield force changes similar to those seen in the 
present study between long SL and short SL resulted in significantly slower loaded 
shortening velocity and a quantitatively similar decrease in peak normalized power 
output as seen in the present study. However, changes in Ca2+ activation alone resulted in 
lower power output at all relative loads, whereas decreased SL seemed to only alter 
loaded shortening and power at loads less than ~40% of isometric force.  This implies 
that a sarcomere length component alters loaded shortening velocity independent of 
changes in thin filament activation.   
 
 78
Sarcomere length dependence of loaded shortening and power output at matched 
levels of thin filament activation. 
We determined if decreased power between long and short SL was due to 
decreased thin filament activation by normalizing thin filament activation levels with 
increased calcium concentration at short SL to match force seen at long SL.  
Interestingly, α-MyHC myocytes exhibited significantly faster loaded shortening 
velocities and increased power output at short SL with matched force when compared to 
long SL, implying increased crossbridge cycling kinetics at short SL.  These increased 
crossbridge kinetics were observed at matched force despite the increased myocyte width 
and lattice spacing that occurs with shorter SL .  This result may arise because α-MyHC 
crossbridges either become more flexible in the azimuthal direction or extend away from 
the thick filament in the radial direction at short SL in addition to, or perhaps resulting in, 
faster kinetics.  In contrast, peak normalized power output in β-MyHC myocytes 
remained significantly depressed at short SL compared to long SL even with matched 
force levels.  This suggests that β-MyHC crossbridges do not undergo as much of an 
increase in azimuthal flexibility or radial extension from the thick filament, at least as 
compared to α-MyHC, and this may explain, in part, why β-MyHC myocytes exhibit a 
greater SL dependent decrease in loaded shortening velocity and power than α-MyHC 
myocytes.    
 
Changes in sarcomere length are known to cause changes in the lateral spacing 
between the thick and thin filament [74, 98], and decreased interfilament spacing induced 
by osmotic compression has been shown to increase force at a given sarcomere length in 
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single skinned cardiac myocytes [102].  Lattice spacing, then, is thought to influence the 
probability of crossbridge formation and thin filament activation by moving toward or 
away from the optimal binding range for myosin.  Thus, another potential mechanism for 
decreased loaded shortening velocity at short SL is the resultant increase in lattice 
spacing, which would lead to less than optimal crossbridge interaction and greater 
cooperative inactivation at the onset of and throughout shortening.  Reduced myocyte 
width and, thus, lattice spacing in our myocytes caused a striking increase in loaded 
shortening velocity and power output in both α-MyHC and β-MyHC.  This certainly 
implies that lattice spacing plays a major role in the reduced loaded shortening velocity 
and power output from long SL to short SL, and further implies faster crossbridge 
kinetics at short SL.  Again, this may be due in part to increased radial crossbridge 
extension from the thick filament at short SL, especially in α-MyHC myocytes.  
Evidence for such a conformational change in cardiac muscle is lacking, but changes in 
radial and azimuthal flexibility have been seen as a consequence of lattice spacing and 
temperature in activated skeletal muscles [21, 89].   
 
Interestingly, it has been shown that phosphorylation of myosin binding protein-C 
by PKA results in extension of crossbridges from the thick filament backbone [180].  
MyBP-C is thought to form a collar around the thick filament, with extensions that bind 
the myosin head in an inhibitory manner [110].  Phosphorylation of MyBP-C has been 
shown to relieve this inhibition and increase force [87] and myocytes from MyBP-C null 
mice have been shown to have increased rates of force development, loaded shortening 
velocity, and power output generating capacity [86, 164].  The thick filament anchoring 
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protein titin is responsible for nearly all of the passive force encountered at physiological 
sarcomere lengths [33, 44], and is known to bind to MyBP-C [33].  It may be possible 
that as the sarcomere length is increased and titin becomes taut, it exerts a force on 
MyBP-C that in turn affects myosin head radial or azimuthal mobility.  Conversely, as SL 
is shortened titin becomes more slack and exerts less force on MyBP-C that in turn 
reduces MyBP-C constraint on myosin head mobility.  Force and power still decrease at 
short SL because interfilament distance is increased and there are fewer myosin 
crossbridges to cooperatively activate the thin filament as there is likely cooperative 
inactivation at the onset of shortening [75, 99].  However, in α-MyHC myocytes, the 
decrease in normalized power output was not as large as might be expected with a 
decrease in SL and, in fact, there was virtually no effect on loaded shortening velocity at 
loads greater than 50% isometric force.  We observed a similar phenomenon in MyBP-C 
null myocytes in which loaded shortening velocities were greatly elevated at high loads.  
This was not observed in wild-type myocytes [86].  Additionally, when thin filament 
calcium activation is increased or the interfilament distance decreased (by osmotic 
compression) at short SL an increase in crossbridge kinetics becomes apparent.  This is 
schematically illustrated in Figure 3.8, where a decrease in SL causes titin to slack, which 
induces a conformational change in MyBP-C that results in release of myosin constraint 
(similar to MyBP-C phosphorylation) and radial extension of myosin heads from the 
thick filament backbone (in α-MyHC).  Interestingly, Weisberg and Winegrad did not see 
a change in β-MyHC crossbridge extension with PKA-phosphorylation of MyBP-C, 
indicating that MyBP-C may have less of an effect on radial extensibility with β-MyHC 
thick filaments [180].  Consistent with this, we observed a much larger decrease in  
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Figure 3.8 
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Figure 3.8:  Crossbridge model of increased kinetics at short SL.   
 
A. Representation of sarcomeric proteins at long SL.  Titin is extended and provides 
passive tension that may help maintain extension of MyBP-C from the thick 
filament to provide constraint on the myosin crossbridge.  B.  At short SL, titin is 
slack and this lack of passive tension may alleviate MyBP-C constraint of the 
crossbridge, which, in α-MyHC, may lead to greater crossbridge extension from 
the thick filament backbone and, in both α-MyHC and β-MyHC, increased 
crossbridge kinetics, similar to that observed with MyBP-C phosphorylation. 
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resulting in slower shortening and lower power.  Furthermore, β-MyHC is more 
susceptible to changes in lattice spacing than is α-MyHC, possibly due to less length 
dependent crossbridge radial extension from the thick filament backbone, which makes it 
less able to maintain thin filament activation during loaded shortening.  This leads to a 
greater difference in power between long and short SL and less of an increase in power 
when force levels are matched.  
Sarcomere length and myosin heavy chain dependence of the force-pCa relationship 
 The decrease in isometric force at short SL compared to long SL, whereby 
maximal Ca2+ activated isometric force at short SL was ~70% of that at long SL in both 
α-MyHC and β-MyHC myocytes, is in agreement with previous studies.  We [85] and 
others [107, 152] previously have shown there is no difference in maximal isometric 
tension between α-MyHC and β-MyHC, as we also observed here.  However, previous 
studies regarding tension-pCa relationship differences between α-MyHC versus β-MyHC 
produced discordant results.  Saponin treated bundles of rabbit myocardium showed no 
difference in Ca2+ sensitivity of force [132], whereas ventricular bundles from 
hypothyroid rat (β-MyHC) were left-shifted (i.e. more sensitive) compared to bundles 
from euthyroid rat (α-MyHC) [40].  Studies utilizing single myocyte preparations also 
have provided mixed results, either demonstrating no change [32] or a right-shift (i.e. less 
sensitive) in the force-pCa relationship with β-MyHC [107].  We hypothesized that these 
discrepancies may arise from different levels of PKA-induced phosphorylation of 
myofibrillar proteins (i.e., MyBP-C and cTnI), which would alter the tension-pCa 
relationship.  We attempted to control this potential variable by maximally 
phosphorylating myofilaments with the catalytic subunit of PKA, and then measuring the 
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tension-pCa relationship.  Regarding PKA treatment, it was previously reported that PKA 
phosphorylation of myofibrillar proteins increased the length dependence of Ca2+ 
sensitivity of isometric force [83], while others have noted that PKA phosphorylation of 
MyBP-C and cTnI does not change sarcomere length dependence of Ca2+ sensitivity 
[174].  In this study, we only measured the tension-pCa relationship following PKA 
treatment in an attempt to discern differences between α-MyHC and β-MyHC.  We found 
that α-MyHC myocytes were less responsive to Ca2+ than β-MyHC myocytes, but that 
there is no MyHC difference in ∆pCa50 in response to sarcomere length changes 
following PKA treatment.  The enhanced Ca2+ sensitivity in β-MyHC may be due to its 
slower duty cycle than α-MyHC that would tend to prolong actin attachment and 
maintain thin filament activation, resulting in less Ca2+ being required to activate the thin 
filament, as has been previously proposed [10].  On the other hand, phosphorylation by 
other kinases such as PKC could be responsible for the different Ca2+ sensitivities 
between α-MyHC and β-MyHC myocytes in this study, but we did not explore this due 
to the wide array of kinases required to maximally phosphorylate all sites. 
 
Sarcomere length and myosin heavy chain dependence on the rate constant of force 
development 
 MyHC has been shown to be a key determinant of the rate of tension development 
, whereby α-MyHC exhibited ~3 times greater rate constant of force development (ktr) 
than β-MyHC in rat skinned ventricular muscle preparations [152].  Our current findings 
are in agreement with that study in that α-MyHC myocytes exhibited ktr values that were 
about twice as fast as β-MyHC myocytes for a given SL or activation level.  The SL 
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dependence of ktr was previously addressed by Adhikari et al. [1], who discovered that 
ktr’s at 2.3 µm and 2.0 µm were comparable at maximal Ca2+ activation and faster at 
force matched submaximal Ca2+ activation in rat skinned cardiac trabeculae.  We also 
saw no difference in ktr at long and short SL in α-MyHC myocytes, but it was higher at 
short SL at the same Ca2+ activation levels as at long SL and when myocyte width was 
matched.  Interestingly, a novel finding of this study is that β-MyHC myocytes exhibited 
higher ktr values at short SL than at long SL despite lower force levels and was even 
higher when at the same level of thin filament activation or the same myocyte width.  
This is somewhat surprising given that β-MyHC myocytes had such a significant 
decrease in power at short SL, but this decrease was likely due, in large part, to the 
increase in myocyte width.  Here again, similar to what was seen with power, the rate of 
force development at short SL with matched force was not significantly different from 
short SL.  However, the rate of force development at short SL with matched width was 
significantly faster than at short SL, again illustrating the susceptibility of β-MyHC to 
width.  Overall, our estimates of the rate constant of force development are in agreement 
with the idea that crossbridge kinetics are inherently greater at short SL in both α-MyHC 
and β-MyHC myocytes. 
 
Physiological significance 
 The Frank-Starling mechanism is a physiological phenomenon that tunes 
myocardial function on a beat-to-beat basis by altering stroke volume, a primary index of 
the heart’s ability to function as a pump [161].  Ventricular function curves plotted as 
end-diastolic volume versus stroke volume have been considered a unifying basis for 
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changes in ventricular function [153], and depression of this relationship is associated 
with heart failure [12, 72, 120, 157, 172].  Interestingly, failing human myocardium has 
increased β-MyHC content [109].  It may be possible that β-MyHC is expressed early in 
the compensatory phase as it is more energetically favorable [50, 71, 91, 152] and 
associated with a slower heart rate [49].  Teleologically, a slower heart rate allows for 
more filling time and, thus, a greater potential end-diastolic volume.  Based on our results 
a heart containing β-MyHC may be more responsive to a change in end-diastolic volume, 
meaning greater reliance on the Frank-Starling relationship as a way to tune ventricular 
power output (i.e., stroke volume).  This is consistent with observations that rat left 
ventricles that had >70% β-MyHC exhibited steeper ventricular function curves than left 
ventricles that contained predominantly α-MyHC [31].  Additionally, we have seen that 
working rat heart preparations that contained primarily α-MyHC had a ~50% increase in 
left ventricular power output when left atrial filling pressure was increased from 7.5 cm 
H2O to 15 cm H2O, whereas hearts containing primarily β-MyHC exhibited an ~150% 
increase in left ventricular power (unpublished data).  
 
It is also interesting that α-MyHC myocytes were less sensitive to Ca2+ than β-
MyHC myocytes.  Because α-MyHC myocytes exhibited faster loaded shortening 
velocity and higher power output, which translates to greater pulse pressure and ejection 
[86], the decrease in Ca2+ sensitivity may be beneficial as it would lead to a more rapid 
thin filament inactivation and more rapid diastolic relaxation.  On the other hand, 
enhanced Ca2+ sensitivity of β-MyHC myocytes may shorten the isovolumic phase of 
contraction and prolong time for ejection.  This, coupled with the observed increase in 
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rate of force development at short SL in β-MyHC myocytes, may be a mechanism for β-
MyHC to maintain adequate stroke volume in the face of decreased EDV.  Most 
interestingly, a main finding of this study is that crossbridge kinetics actually are 
increased at short SL in both α-MyHC and β-MyHC.  This may help maintain ventricular 
power with decreased end-diastolic volumes and help sustain adequate blood flow to the 
heart and periphery when venous return is compromised.     
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Chapter 4.    DISCUSSION 
 
4.1 Summary of Results 
 
The heart’s pumping performance is determined by factors intrinsic to the 
myocardium, and can be altered on a beat-to-beat basis through changes in sarcomere 
length or Ca2+ sensitivity, or long-term through changes in myofilament protein isoform 
expression.  The pumping action occurs when individual myocytes undergo loaded 
shortening in response to activation.  My work has primarily focused on the effects of 
sarcomere length and thick filament protein expression on loaded shortening velocity and 
power output in single skinned cardiac myocytes.  I have determined the effect of 
ablation of the thick filament protein MyBP-C on force, rate of force development, 
loaded shortening velocity, and power output in mouse skinned cardiac myocytes.  
Ablation of MyBP-C resulted in increased loaded shortening velocity and power output 
during maximal and half-maximal Ca2+ activation, and this effect was more pronounced 
during half-maximal Ca2+ activation (Figures 2.2 and 2.3).  Furthermore, the rate of force 
development also was increased with MyBP-C ablation, but only during half-maximal 
Ca2+ activation (Figure 2.4).  This underscores the importance of MyBP-C in regulating 
myocardial function, as the myocardium in vivo is thought to mostly encounter half-
maximal Ca2+ concentrations. 
   
 The effects of sarcomere length on force, Ca2+ sensitivity of force, rate of force 
development, loaded shortening velocity and power output were determined in rat 
skinned cardiac myocytes as well.  Moreover, because β-MyHC is upregulated with heart 
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failure, and heart failure is associated with a reduced Frank-Starling mechanism, 
sarcomere length dependence was determined in myocytes containing either α-MyHC or 
β-MyHC to assess potential MyHC dependence of sarcomere length responsiveness.  
Decreasing sarcomere length from 2.3 µm to 2.0 µm resulted in decreased peak absolute 
and normalized loaded shortening velocity and power output in both α-MyHC and β-
MyHC myocytes, but the effect was more pronounced in β-MyHC myocytes.  Changing 
sarcomere length from 2.3 µm to 2.0 µm, however, had no effect on the rate of force 
development in α-MyHC myocytes and actually increased the rate of force development 
in β-MyHC myocytes.  Because decreasing sarcomere length results in decreased thin 
filament activation, the effect of sarcomere length also was measured in myocytes with 
matched levels of thin filament activation as indexed by force.  This resulted in faster 
loaded shortening velocity at short SL and increased power to values that even exceeded 
those seen at long SL in α-MyHC myocytes.  β-MyHC myocytes experienced increased 
loaded shortening velocity at high loads, but peak power remained depressed at short SL 
with matched force.  The rate of force development in both α-MyHC and β-MyHC 
myocytes was faster at short SL with matched force than at long SL.  Another 
consequence of decreasing sarcomere length is an increase in myocyte width and 
interfilament lattice distance.  Thus, the effect of sarcomere length also was measured in 
myocytes with matched width brought about by application of the osmotic polymer 
dextran.  Loaded shortening velocity, power output, and the rate of force development 
were increased at short SL with matched myocyte width as compared to long SL in both 
α-MyHC and β-MyHC.  Taken together, these results imply that crossbridge cycling is 
increased at short SL.  Finally, MyHC dependence of Ca2+ sensitivity of force was 
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examined at both long and short SL following treatment with PKA in an attempt to 
normalize for differences in basal PKA-induced phosphorylation.  β-MyHC myocytes 
were found to be more sensitive to Ca2+ than α-MyHC myocytes, but there was no 
difference in their change in Ca2+ sensitivity of force with changes in sarcomere length..   
Overall, these results provide a molecular and cellular basis for functional changes 
that occur with the Frank-Starling relationship, and how that relationship can be altered 
with myocardial plasticity.  
 
 
4.2 Effects of MyBP-C on Myocardial Function 
 
The data presented here are consistent with the idea that MyBP-C normally acts to 
limit crossbridge kinetics by constraining myosin-actin interaction.  In the past, it was 
postulated that it does so by tethering the crossbridges to the thick filament backbone to 
limit the range of crossbridge movement [15, 68, 69], and that phosphorylation relieved 
this constraint [39, 46].  More recent evidence suggests that MyBP-C may exert its 
effects independent of a tether mechanism.  Addition of MyBP-C fragments consisting of 
the N-terminal, S2-binding C1C2 portion of the molecule, which lack binding sites for 
the rod portion of myosin and are, thus, “untethered”, resulted in increased myofilament 
Ca2+ sensitivity in normal myocardium [53].  There also was an increase in Ca2+ 
sensitivity in myocardium lacking MyBP-C with the addition of the C1C2 fragment [53], 
indicating that the fragment is not simply competing away endogenous MyBP-C, but is 
instead likely directly affecting myosin crossbridges perhaps by binding the S2 region of 
myosin and altering its conformation and, thus, its interaction with actin.  Furthermore, 
phosphorylation of this fragment reduced its ability to enhance Ca2+ sensitivity [53], 
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implying its interaction with myosin was attenuated.  This strengthens the argument that 
phosphorylation of MyBP-C results in a reduction in its interaction with myosin 
crossbridges.  Another recent study showed that high concentrations of the MyBP-C 
fragment C0C2 can activate force production in the absence of Ca2+ [63].  The author’s 
attribute this to a direct effect of the C0C2 fragment on myosin crossbridges, because 
immunohistochemical analysis showed no evidence for C0C2 interaction with proteins in 
the I-band (thin filament only) or the H-zone (myosin backbone only).  Again, this 
implies that MyBP-C affects myosin independent of a tether mechanism and MyBP-C 
may directly affect crossbridge interactions with thin filaments.  Interestingly, this study 
also showed that lower concentrations of C0C2 increased myofibrillar Ca2+ sensitivity, 
but only at SL of 1.9 µm and not at SL of 2.3 µm [63].  This provides evidence that 
MyBP-C may be involved in mediating the sarcomere length dependence of cross-bridge 
position and is consistent with my model whereby alleviation of titin strain allosterically 
alters the interaction between MyBP-C and myosin.   
 
A major discrepancy arising from my study is that we saw enhanced contractile 
function in myocytes lacking MyBP-C, while hearts that either lack MyBP-C or express 
truncated MyBP-C demonstrate contractile dysfunction in vivo [52, 133, 134].  Hearts 
that contained truncated MyBP-C or lacked MyBP-C presented with similar phenotypes 
including increased mass, decreased ejection fraction in vivo, and left ventricular 
chamber dilation.  Interestingly, the maximal rate of pressure development was no 
different in MyBP-C truncated or ablated hearts and their respective controls, whereas the 
rate of pressure decline was much slower in MyBP-C truncated and ablated hearts.  This 
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is very similar to an observation that intact rat ventricular myocytes showed decreased 
time to half-relaxation when MyBP-C binding to endogenous myosin S2 was 
competitively reduced by addition of exogenous myosin S2 [15].  This putative 
slowdown in relaxation in MyBP-C truncated/ablated mice implies that these hearts 
experience compensated hemodynamic loads due to less time for ventricular filling.  
Decreased ventricular filling would lead to decreased stroke volume in accordance with 
the Frank-Starling relationship.  An additional factor thought to reduce ejection fraction 
in MyBP-C truncated/ablated mice seems to arise from a marked abbreviation of systolic 
ejection.  The exact mechanism for this abbreviation is unclear but has been proposed to 
arise from the notable reduction in the stiffness of myosin crossbridges in MyBP-C 
ablated/truncated hearts [133, 134].  Here again, MyBP-C seems to provide a stabilizing 
constraint to myosin that enables it to maintain low compliant, strong crossbridge binding 
to actin that, in turn, sustains thin filament activation.  So, in myocytes lacking MyBP-C, 
the crossbridges are more compliant and therefore accelerate thin filament inactivation 
that normally occurs during ejection [100].  So, for example, during normal ejection as 
myocytes shorten, the spacing between the thick and thin filament increases, reducing the 
probability of myosin strongly interacting with actin.  In addition, it is well known that 
the intracellular Ca2+ concentration is transient, and therefore declining, throughout 
systole.  Thus, the intracellular environment favors thin filament inactivation as systole 
proceeds (due to both decreasing levels of activating calcium and decreasing numbers of 
strongly bound myosin crossbridges).    For the situation of myocytes lacking MyBP-C, 
the more compliant crossbridges would tend to accelerate this process and lead to 
truncated ejection because the myocytes are unable to sustain the load needed to keep the 
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aortic valve open in the face of systolic arterial pressures.  Interestingly, I propose that 
these more compliant, less constrained crossbridges (due to the lack of MyBP-C) also can 
lead to slower relaxation.  While these crossbridges are unable to sustain systolic loads, 
their enhanced range of motion prevents full thin filament inactivation due to their 
propensity to interact with actin, which prolongs isovolumic relaxation and leaves less 
time for filling.   
An alternative mechanism for systolic dysfunction in MyBP-C truncated/ablated 
hearts arises from a recent study that showed that MyBP-C ablation accelerated stretch 
activation [164].  First identified in insect flight muscle by J.W.S. Pringle in 1949, the 
stretch-activation response takes advantage of a property that generates oscillatory power 
output in the presence of a persistently elevated calcium concentration [142].  When 
activated muscle is subjected to a quick stretch, there is a nearly instantaneous increase in 
force which quickly decays.  Then, even though the muscle remains in an isometric state, 
there is second rise in tension.  This delayed second rise in tension is the hallmark of the 
stretch-activation response, and is governed by a time delay that seems to be related to 
the resonant frequency of maximal power output in an oscillating system such as beating 
insect wings or a beating heart [16].  Stretch activation, therefore, may be an important 
mechanism for regulation of heart function including myocardial power generation and 
ejection.  In fact, mathematical modeling suggests that stretch-activation uses crossbridge 
activation to help determine the steepness of the Frank-Starling relationship [16].  A 
consequence of reliance on crossbridge activation, however, would also likely enhance 
inactivation of crossbridges during muscle shortening.  Experimentally, this was observed 
when ablation of MyBP-C was shown to accelerate stretch activation in mouse skinned 
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myocardium [163], and as discussed above, also apparently accelerates crossbridge 
inactivation during ejection [134].  This also is interesting in light of the torsional aspect 
to cardiac contraction noted in the introduction [16, 23, 165, 177].  Torsional motion is 
wrought by the orientation of cardiac myofibers which form a left-handed helix on the 
epicardium  from the apex to the base while the endocardial surface spirals in a counter 
right-handed helix [167].  Epicardial fibers are known to dominate over endocardial 
fibers during ejection, thus ‘weaker’ endocardial fibers are effectively being stretched at 
the onset of systole, which may initiate the stretch-activation response that results in a 
delayed tension peak near the end of systole when force would otherwise be declining.  
Accelerated stretch activation due to lack of MyBP-C may result in premature force 
development in subendocardial regions of the heart that eliminates the delayed tension 
development that helps maintain ejection, which could account for the observed sudden 
abbreviation in systolic ejection.   
 
There is another aspect to muscle contraction that shares many similarities with 
stretch-activation: the overshoot in tension that occurs following a slack-restretch 
maneuver such as for the measurement of rate of force development.  Following a rapid 
shortening and restretch protocol, tension often temporarily exceeds isometric tension 
before eventually declining to the original steady-state value, especially when muscle is 
activated with submaximal Ca2+ [17].  We do not normally observe tension overshoot 
because our typical tension recovery records are cut off prior to overshoot occurring.  
Using a longer time scale record has revealed tension overshoots in a number of different 
muscle preparations [17, 18, 104, 145].  Interestingly, tension overshoots typically occur 
 94
in skinned cardiac preparations, but are notably absent following MyBP-C extraction and 
in MyBP-C ablated myocardium (unpublished observations, conversations with K.S. 
Campbell and K.S. McDonald).  Recall that MyBP-C ablated myocardium has a faster 
rate of force development at submaximal Ca2+ activations, and accelerated stretch 
activation.  The lack of overshoot implies that the accelerated stretch-activation helped 
speed the rate of force development, but the acceleration has diminished by the time 
overshoot normally occurs.  I have proposed a model (Figure 3.8) whereby a 
conformational change in MyBP-C that occurs between long and short sarcomere length 
is responsible for the increase in crossbridge kinetics seen at short SL when force is 
normalized, and that titin may be involved in transduction of passive force, or lack 
thereof, to MyBP-C to initiate the conformational change.  This can be tested 
experimentally by measuring mechanical properties before and after titin degradation by 
mild trypsin digestion, which has been shown to preferentially degrade titin without 
affecting other sarcomeric proteins [35, 37, 44, 57].  Cleavage of titin should speed the 
rate of force development and eliminate tension overshoot similar to MyBP-C ablation.  
Indeed, titin cleavage did result in increased rate of force development and elimination of 
tension overshoot (Figure 4.1), implying that titin affects crossbridge interaction with the 
thin filament either directly or indirectly through MyBP-C as proposed.  The possibility 
exists that titin may be interacting with and stretching the thin filaments during restretch, 
which may activate regulatory units and allow more crossbridges to bind, leading to 
tension overshoot.  However, increased availability of regulatory units would tend to 
increase the rate of force development, which is actually increased when titin is degraded 
and unavailable to exert activating effects on the thin filament. 
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Figure 4.1: Tension overshoot in skinned cardiac myocytes before and after titin 
degradation. 
 
Normal myocardium at submaximal Ca2+ activation shows evidence of transient tension 
overshoot following rapid shortening to slack length and restretching to original length.  
Titin degradation following trypsin treatment abolishes the tension overshoot and speeds 
the rate of force development. 
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 Furthermore, I showed that the rate of force development is faster or unchanged at 
short sarcomere length as compared to long sarcomere length, when titin is slack and not 
exerting any passive force that could potentially activate the thin filament.  Expanding the 
recorded time scale should also show that tension overshoot is depressed at short 
sarcomere length, which we observed as well (data not shown).  Cleavage of titin by mild 
trypsin digestion should also speed loaded shortening velocity and increase power output 
similar to MyBP-C ablation.  Experimental results, though, show that there was no 
significant change in loaded shortening velocity or power output following titin 
degradation (data not shown).  However, there are a number of potential explanations for 
this result.  First, titin is the number one contributor to passive tension in cardiac 
myocytes [36, 44, 122], and passive tension has been correlated with active force 
production [20, 37, 124].  Thus, degradation of passive force would be expected to 
decrease active force production, which would tend to slow loaded shortening velocity.  
In this experiment, passive force declined with trypsin treatment, but there was no 
difference in isometric force.  Second, titin, when stretched, may then be able to assist 
with loaded shortening, as it has been shown to increase unloaded shortening velocity 
[108], probably by passive recoil.  If this were the case, degradation of titin would tend to 
slow loaded shortening velocity, which, when coupled with a subsequent MyBP-C 
mediated increase in loaded shortening velocity, may offset and present as no change as 
observed.  Finally, SDS-agarose-PAGE analysis designed specifically for detection of 
titin showed that we degraded approximately 30-35% of titin content (data not shown).  
This may be enough to account for changes we have seen in rate of force development 
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and tension overshoot, but not enough to cause differences in loaded shortening velocity 
and power.  There are 6 titins per thin filament so, assuming a stoichiometric ratio, our 
trypsin degradation would still leave ~4 titins per thick filament.  The interpretation of 
the results would be clarified with more complete degradation of titin. 
 
It also may be possible that titin is opposing loaded shortening velocity by providing an 
internal load.  In vitro motility assays demonstrated that the PEVK region of titin 
interacted with actin to slow filament sliding, and it was suggested that similar action in 
cardiac myocytes may occur. The calcium binding protein S100A1 was shown to relieve 
the PEVK-actin interaction in a Ca2+ dependent manner, leading the authors to speculate 
that S100A1 could reduce passive resistance during contraction.  We tested this 
hypothesis by addition of exogenous S100A1 to skinned cardiac myocytes.  There was no 
difference in loaded shortening velocity or power output before or after addition of 
exogenous S100A1 (Figure 4.2).  Furthermore, there was no endogenous S100A1 present 
to confound these results, as shown using western blot with an antibody to S100A1 (data 
not shown).  Taken together, these results suggest that titin is not providing an internal 
load.  Overall, our results regarding tension overshoot before and after trypsin 
degradation coupled with similar results following MyBP-C extraction or ablation 
support our model whereby titin-MyBP-C interaction regulates, at least in part, sarcomere 
length dependence of myocyte function. 
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Figure 4.2: Force-velocity and power load curves before and after treatment with 
S100A1 
 
There was no difference in loaded shortening velocity between control, treatment with 
S100A1 for 20 minutes, or incubation with S100A1 for 1 hour. 
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4.3 Role of MyHC in sarcomere length dependence of mechanical properties 
 
 The studies in this dissertation demonstrate that crossbridge cycling rates are 
increased at short SL as compared to long SL, which may be due to an increase in myosin 
flexibility that results in crossbridge extension from the thick filament.  X-ray diffraction 
is a useful tool that may provide insight into the possibility of crossbridge orientation 
following changes in sarcomere length.  For example, the intensity of M3 meriodonal 
reflection is thought to arise from axial repeats of myosin heads along the thick filament 
[144].  An increase in intensity of the M3 reflection suggests that the heads become more 
perpendicular to the thick filament; i.e., they extend away from the thick filament.  It has 
already been seen that increasing temperature from 0 to 17 in frog skeletal muscle 
intensified the M3 reflection during isometric contraction, correlating with the 
temperature dependent increase in force [89].  M3 reflections also were found to change 
with sarcomere length, but appeared to be due completely to the degree of overlap 
between thick and thin filaments.  This is to be expected for skeletal muscle that was used 
for these experiments, which has a much shallower length-tension relationship than 
cardiac muscle.  To the best of my knowledge, the effects of sarcomere length changes on 
the M3 reflections in cardiac muscle has not been examined, but would likely provide 
insight into the structural mechanism that governs the steep length-tension relationship in 
cardiac muscle. 
 
Light microscopy is another way of testing whether crossbridges extend farther 
away from the thick filament backbone at shortened sarcomere length.  As noted in the 
introduction, muscle is strongly birefringent; it polarizes light.  Muscle birefringence 
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arises from the anisotropic band of the sarcomere, which is known to be caused by 
myosin.  Use of interference microscopy can be used to assess changes in birefringence 
that reflects movement of myosin crossbridges.  A greater birefringence value is thought 
to be due to the myosin S-2 fragment (which interacts with and is bound by MyBP-C) 
moving closer to the thick filament shaft, while a smaller birefringence value is due to S-
2 away from the thick filament backbone [159].  The model for sarcomere length 
dependent changes in loaded shortening velocity proposed in this dissertation is that 
myosin is extended away from the thick filament at short sarcomere length, speeding 
crossbridge cycling.  Birefringence, therefore, may be able to detect changes in the 
thickness of the thick filament in response to changes in sarcomere length that can be 
correlated with myosin extension. 
 
4.4 Conclusion 
The studies in this dissertation show that when thin filament activation levels are matched 
loaded shortening velocity and power output are actually increased at short SL compared 
to long SL.  Loaded shortening velocity and power output also were shown to increase in 
myocytes lacking MyBP-C compared to control myocytes.  The mechanism(s) for the 
increased loaded shortening velocity and power output in both these experimental 
manipulations is proposed to be similar.  I have proposed a model in which the sarcomere 
length dependence of power arises from a conformational change in MyBP-C, whereby 
the stabilizing constraint of MyBP-C on myosin cross-bridges is alleviated at short 
sarcomere length because of less stress imposed by titin.  Titin has been shown to be 
primarily responsible for passive tension in cardiac and skeletal muscle and titin may 
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transmit this passive tension to MyBP-C, eliciting a conformation in MyBP-C that 
stabilizes its interaction with myosin.  At short sarcomere length, passive tension is 
reduced or eliminated, which would alleviate the conformational stability of MyBP-C on 
myosin, resulting in more extensible (and also more compliant crossbridges).  These 
crossbridges would tend to accelerate rates of force development and rates of loaded 
shortening by perhaps faster crossbridge interaction kinetics per se and, even more likely, 
altered recruitment of thin filament regulatory units by cross-bridges.  Experiments are 
needed to directly test this theory; such experiments would include mechanical 
measurements before and after more complete titin degradation and x-ray and light 
diffraction measurements to assess crossbridge extensibility and binding in response to 
changes in sarcomere length and MyBP-C truncation/ablation/extraction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 102
LITERATURE CITED 
 
 
1. Adhikari, B.B., et al., Cardiac length dependence of force and force development 
kinetics with altered cross-bridge cycling. Biophysical Journal, 2004. 87: p. 1784-
1794. 
2. Allen, D.G. and J.R. Blinks, Calcium transients in aequorin-injected frog cardiac 
muscle. Nature, 1978. 273: p. 509-513. 
3. Allen, D.G., B.R. Jewell, and J.W. Murray, The contribution of activation 
processes to the length-tension relation in cardiac muscle. Nature, 1974. 248: p. 
509-513. 
4. Allen, D.G. and J.C. Kentish, The cellular basis of the length-tension relation in 
cardiac muscle. Journal of Molecular and Cellular Cardiology, 1985. 17: p. 821-
840. 
5. Allen, D.G. and S. Kurihara, The effects of muscle length on intracellular calcium 
transients in mammalian cardiac muscle. Journal of Physiology, 1982. 327: p. 79-
84. 
6. Alpert, J.S., P. Peterson, and J. Godtfredsen, Atrial fibrillation: natural history, 
complications and management. Annual Review of Medicine, 1988. 39: p. 41-52. 
7. Alpert, N.R., et al., Molecular mechanics of mouse cardiac myosin isoforms. 
American Journal of Physiology, 2002. 283: p. H1446-H1454. 
8. Babu, A., E.H. Sonnenblick, and J. Gulati, Molecular basis for the influence of 
muscle length on myocardial performance. Science, 1988. 240: p. 74-76. 
9. Bennett, P., et al., The ultrastructural location of C-protein, X-protein, and H-
protein in rabbit muscle. Journal of Muscle Research and Cell Motility, 1986. 7: 
p. 550-567. 
10. Brandt, P.W., et al., Regulation of tension in skinned muscle fibers. Journal of 
Molecular Biology, 1982. 79: p. 997-1016. 
11. Braunwald, E., et al., Studies on Starling's law of the heart. Journal of Clinical 
Investigation, 1960. 39: p. 1874-1884. 
12. Braunwald, E., J. Ross, and E.H. Sonnenblick, Mechanisms of contraction in the 
normal and failing heart. New England Journal of Medicine, 1967. 277: p. 1012-
1022. 
13. Bremel, R.D. and A. Weber, Cooperation within actin filament in vertebrate 
skeletal muscle. Nature New Biology, 1972. 238: p. 97-101. 
14. Brenner, B. and E. Eisenberg, Rate of force generation in muscle: correlation 
with actomyosin ATPase activity in solution. Proceedings of the National 
Academy of Sciences of the USA, 1986. 83: p. 3542-3546. 
15. Calaghan, S.C., et al., A role for C-protein in the regulation of contraction and 
intracellular Ca2+ in intact rat ventricular myocytes. Journal of Physiology, 2000. 
528.1: p. 151-156. 
16. Campbell, K.B. and M. Chandra, Functions of stretch activation in heart muscle. 
Journal of General Physiology, 2006. 127: p. 89-94. 
17. Campbell, K.S., Tension recovery in permeabilized rat soleus muscle fibers after 
rapid shortening and restretch. Biophysical Journal, 2006. 90: p. 1288-1294. 
 103
18. Campbell, K.S. and R.L. Moss, History-dependent mechanical properties of 
permeabilized rat soleus muscle fibers. Biophysical Journal, 2002. 82: p. 929-943. 
19. Carrier, L., et al., Organization and sequence of human cardiac myosin binding 
protein C gene (MYBPC3) and identification of mutations predicted to produce 
truncated proteins in familial hypertrophic cardiomyopathy. Circulation 
Research, 1997. 80: p. 427-434. 
20. Cazorla, O., et al., Titin-based modulation of calcium sensitivity of active tension 
in mouse skinned cardiac myocytes. Circulation Research, 2001. 88: p. 1028-
1035. 
21. Cecchi, G., et al., Detection of radial crossbridge force by lattice-spacing changes 
in intact single muscle fibers. Science, 1990. 250: p. 1409-1411. 
22. Chizzonite, R.A., et al., Comparison of myosin heavy chains in atria and 
ventricles from hyperthyroid, hypothyroid, and euthyroid rabbits. Journal of 
Biological Chemistry, 1984. 259(24): p. 15564-71. 
23. Davis, J.S., et al., The overall pattern of cardiac contraction depends on a spatial 
gradient of myosin regulatory light chain phosphorylation. Cell, 2001. 107: p. 
631-641. 
24. De Tombe, P.P. and E.D.J. ter Keurs, An internal viscous element limits unloaded 
velocity of sarcomere shortening in rat cardiac trabeculae. Journal of Physiology, 
1992. 454: p. 619-642. 
25. Dillman, W.H., Diabetes mellitus induces changes in cardiac myosin of the rat. 
Diabetes, 1980. 29: p. 579-582. 
26. Edman, K.A.P., The velocity of unloaded shortening and its relation to sarcomere 
length and isometric force in vertebrate muscle fibers. Journal of Physiology, 
1979. 291: p. 143-159. 
27. Fabiato, A., Myoplasmic free calcium concentration reached during the twitch of 
an intact isolated cardiac cell and during calcium-induced release of calcium 
from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or 
rabbit ventricle. Journal of General Physiology, 1981. 78: p. 457-497. 
28. Fabiato, A. and F. Fabiato, Dependence of the contractile activation of skinned 
cardiac cells on the sarcomere length. Nature, 1975. 256: p. 54-56. 
29. Fabiato, A. and F. Fabiato, Myofilament-generated tension oscillations during 
partial calcium activation and activation dependence of the sarcomere length-
tension relation of skinned cardiac cells. Journal of General Physiology, 1978. 72: 
p. 667-699. 
30. Fitzsimmons, D.P., J.R. Patel, and R.L. Moss, Role of myosin heavy chain 
composition in kinetics of force development and relaxation in rat myocardium. 
Journal of Physiology, 1998. 513: p. 171-183. 
31. Fitzsimons, D.P., D.P. Patel, and R.L. Moss, Aging-dependent depression in the 
kinetics of force development in rat skinned myocardium. Am J Physiol Heart 
Circ Physiol, 1999. 276: p. H1511-H1519. 
32. Fitzsimons, D.P., J.R. Patel, and R.L. Moss, Role of myosin heavy chain 
composition in kinetics of force development and relaxation in rat myocardium. 
Journal of Physiology, 1998. 513: p. 171-183. 
33. Freiburg, A. and M. Gautel, A molecular map of the interactions between titin and 
myosin binding protein C.  Implications for sarcomeric assembly in familial 
 104
hypertrophic cardiomyopathy. European Journal of Biochemistry, 1996. 235: p. 
317-323. 
34. Fuchs, F. and D.A. Martyn, Length-dependent calcium activation in cardiac 
muscle: some remaining questions. Journal of Muscle Research and Cell Motility, 
2005. 
35. Fukuda, N., et al., Length dependence of tension generation in rat skinned cardiac 
muscle. Circulation, 2001. 104: p. 1639-1645. 
36. Fukuda, N., et al., Titin isoform variance and length dependence of activation in 
skinned bovine cardiac muscle. Journal of Physiology, 2003. 533.1: p. 147-154. 
37. Fukuda, N., et al., Titin-based modulation of active tension and interfilament 
lattice spacing in skinned rat cardiac muscle. Pflugers Archive - European 
Journal of Physiology, 2005. 449: p. 449-457. 
38. Garber, D.W. and J.R. Neely, Decreased myocardial function and myosin ATPase 
in hearts from diabetic rats. American Journal of Physiology, 1983. 244(4): p. 
H586-91. 
39. Gautel, M., et al., Phosphorylation switches specific for the cardiac isoform of 
myosin binding protein C: a modulator of cardiac contraction? EMBO Journal, 
1995. 14: p. 1952-1960. 
40. Gibson, L.M., I.R. Wendt, and D.G. Stephenson, Contractile activation properties 
of ventricular myocardium from hypothyroid, euthyroid, and juvenile rats. Pfluger 
Archives, 1992. 422: p. 16-23. 
41. Gilbert, R., et al., The carboxy terminus of myosin binding protein C (MyBP-C, C-
protein) specifies incorporation into the A-band of striated muscle. Journal of Cell 
Science, 1996. 109: p. 101-111. 
42. Gordon, A.M., E. Homsher, and M. Regnier, Regulation of contraction in striated 
muscle. Physiological Reviews, 2000. 80: p. 853-924. 
43. Gordon, A.M., A.F. Huxley, and F.J. Julian, The variation in isometric tension 
with sarcomere length in vertebrate muscle fibers. Journal of Physiology, 1966. 
184: p. 170-192. 
44. Granzier, H.L. and T.C. Irving, Passive tension in cardiac muscle: Contribution 
of collagen, titin, microtubules, and intermediate filaments. Biophysical Journal, 
1995. 68: p. 1027-1044. 
45. Grimm, A.F., H. Lin, and B.R. Grimm, Left ventricular free wall and 
intraventricular pressure-sarcomere length distributions. Am J Physiol Heart 
Circ Physiol, 1980. 239: p. H101-H107. 
46. Gruen, M., H. Prinz, and M. Gautel, cAPK-phosphorylation controls the 
interaction of the regulatory domain of cardiac myosin binding C with myosin-S2 
in an on-off fashion. FEBS Letters, 1999. 453: p. 254-259. 
47. Guccione, J.M., et al., Anterior and posterior left ventricular sarcomere lengths 
behave similarly during ejection. American Journal of Physiology, 1997. 272: p. 
H469-H477. 
48. Guth, K. and J.D. Potter, Effect of rigor and cycling cross-bridges on the structure 
of troponin C and on the Ca2+ affinity of the Ca2+-specific regulatory sites in 
skinned rabbit psoas fibers. Journal of Biological Chemistry, 1987. 262: p. 
13627-13635. 
 105
49. Hamilton, N. and C.D. Ianuzzo, Contractile and calcium regulating capacities of 
myocardia of different sized mammals scale with resting heart rate. Molecular 
and Cellular Biochemistry, 1991. 106: p. 133-141. 
50. Harris, D.E., et al., Smooth, cardiac, and skeletal muscle myosin force and motion 
generation assessed by cross-bridge mechanical interactions in vitro. Journal of 
Muscle Research and Cell Motility, 1994. 15: p. 11-19. 
51. Harris, S.P., et al., Hypertrophic cardiomyopathy in cardiac myosin binding 
protein-C knockout mice. Circulation Research, 2002. 90: p. 594-601. 
52. Harris, S.P., et al., Targeted ablation of the mouse cardiac myosin binding 
protein-C gene. Biophysical Journal, 2001. 80: p. 89A. 
53. Harris, S.P., et al., Binding of myosin binding protein-C to myosin subfragment S2 
affects contractility independent of a tether mechanism. Circulation Research, 
2004. 95: p. 930-936. 
54. Harrison, S.M., C. Lamont, and D.J. Miller, Hysteresis and the length dependence 
of calcium sensitivity in chemically-skinned rat cardiac muscle. Journal of 
Physiology, 1988. 401: p. 115-143. 
55. Hartzell, H.C., Effects of phosphorylation and unphosphorylated C-protein on 
cardiac actomyosin ATPase. Journal of Molecular Biology, 1985. 186: p. 185-
195. 
56. Harvey, W., On the motion of the heart and blood in animals. The Harvard 
Classics, 2004. 38(Scientific Papers). 
57. Helmes, M., et al., Titin determines the Frank-Starling relation in early diastole. 
Journal of General Physiology, 2003: p. 97-110. 
58. Herron, T.J., et al., Age dependence of isometric crossbridge cycling and α-
MyHC isoform expression in human ventricular myocytes. Biophysical Journal, 
2005. 
59. Herron, T.J., et al., Power output varies as a linear function of β-myosin heavy 
chain in both single rat cardiac myocytes and whole hearts. Biophysical Journal, 
2002. 82: p. 399a. 
60. Herron, T.J., F.S. Korte, and K.S. McDonald, Loaded shortening and power 
output in cardiac myocytes are dependent on myosin heavy chain isoform 
expression. American Journal of Physiology, 2001. 281: p. H1217-1222. 
61. Herron, T.J., F.S. Korte, and K.S. McDonald, Power output is increased after 
phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes. 
Circulation Research, 2001. 89: p. 1184-1190. 
62. Herron, T.J. and K.S. McDonald, Small amounts of α-myosin heavy chain isoform 
expression significantly increase power output of rat cardiac myocyte fragments. 
Circulation Research, 2002. 90: p. 1150-52. 
63. Herron, T.J., et al., Activation of myocardial contraction by the N-terminal 
domains of myosin binding protein-C. Circulation Research, 2006. 98: p. 1290-
1298. 
64. Hibberd, M.G. and B.R. Jewell, Calcium- and length-dependent force production 
in rat ventricular muscle. Journal of Physiology, 1982. 329: p. 527-540. 
65. Hill, A.V., The heat of shortening and the dynamic constants of muscle. Proc. R. 
Soc. London Ser. B., 1938. 126: p. 136-195. 
 106
66. Hofmann, P.A. and F. Fuchs, Effect of length and cross-bridge attachment on 
Ca2+  binding to cardiac troponin C. American Journal of Physiology, 1987. 253: 
p. C90-C96. 
67. Hofmann, P.A. and F. Fuchs, Bound calcium and force development in skinned 
cardiac muscle bundles: effect of sarcomere length. Journal of Molecular and 
Cellular Cardiology, 1988. 20: p. 667-677. 
68. Hofmann, P.A., M.L. Greaser, and R.L. Moss, C-Protein limits shortening 
velocity of rabbit skeletal muscle fibres at low levels of Ca2+ activation. Journal of 
Physiology, 1991. 439: p. 701-715. 
69. Hofmann, P.A., H.C. Hartzell, and R.L. Moss, Alterations in Ca2+ sensitive 
tension due to partial extraction of C-protein from rat skinned cardiac myocytes 
and rabbit skeletal muscle. Journal of General Physiology, 1991. 97: p. 1141-
1163. 
70. Hoh, J.F.Y., P.A. McGrath, and P.T. Hale, Electrophoretic analysis of multiple 
forms of rat cardiac myosin: effects of hypophysectomy and thyroxine 
replacement. Journal of Molecular and Cellular Cardiology, 1977. 10: p. 1053-
1076. 
71. Holubarsch, C., et al., The economy of isometric force development, myosin 
isozyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat 
myocardium. Circulation Research, 1985. 56: p. 78-86. 
72. Holubarsch, C., et al., Existence of the Frank-Starling mechanism in the failing 
human heart.  Investigations on the organ, tissue, and sarcomere levels. 
Circulation, 1996. 94(4): p. 683-689. 
73. Huxley, H.E. and W. Brown, The low-angle x-ray diagram of vertebrate striated 
muscle and its behaviour during contraction and relaxation. Journal of Molecular 
Biology, 1967. 30: p. 383-434. 
74. Irving, T.C., et al., Myofilament lattice spacing as a function of sarcomere length 
in isolated rat myocardium. American Journal of Physiology, 2000. 279: p. 
H2568-H2573. 
75. Iwamoto, I., Thin filament cooperativity as a major determinant of shortening 
velocity in skeletal muscle fibers. Biophysical Journal, 1998. 74: p. 1452-1464. 
76. Jacob, R., B. Dierberger, and G. Kissling, Functional significance of the Frank-
Starling mechanism under physiological and pathophysiological conditions. 
European Heart Journal, 1992. 13(Supplement E): p. 7-14. 
77. Janssen, P.M.L. and P.P. De Tombe, Protein kinase A does not alter unloaded 
velocity of sarcomere shortening in skinned rat cardiac trabeculae. American 
Journal of Physiology (Heart Circ. Physiol.), 1997. 42: p. H2415-H2422. 
78. Kanaya, N., et al., Propofol increases phosphorylation of troponin I and myosin 
light chain 2 via protein kinase C activation in cardiomyocytes. Anesthesiology, 
2003. 98: p. 1363-71. 
79. Kentish, J.C., et al., Comparison between the sarcomere length-force relations of 
intact and skinned trabeculae from rat right ventricle. Circulation Research, 
1986. 58: p. 755-768. 
80. Kitzman, D.W., et al., Exercise intolerance in patients with heart failure and 
preserved left ventricular systolic function: failure of the Frank-Starling 
 107
mechanism. Journal of the American College of Cardiology, 1991. 17: p. 1065-
1072. 
81. Komamura, K., et al., Exhaustion of Frank-Starling mechanism in conscious dogs 
with heart failure. American Journal of Physiology, 1993. 265: p. H1119-H1131. 
82. Konhilas, J.P., T.C. Irving, and P.P. de Tombe, Myofilament calcium sensitivity in 
skinned rat cardiac trabeculae. Circulation Research, 2002. 90: p. 59-65. 
83. Konhilas, J.P., et al., Troponin I in the murine myocardium: influence on length-
dependent activation and interfilament spacing. Journal of Physiology, 2003. 547: 
p. 951-961. 
84. Koretz, J.F., Effects of C-Protein on synthetic myosin filament structure. 
Biophysical Journal, 1979. 27: p. 443-446. 
85. Korte, F.S., et al., Power output is linearly related to MyHC content in rat skinned 
myocytes and isolated working hearts. Am J Physiol Heart Circ Physiol, 2005. 
289(2): p. H801-812. 
86. Korte, F.S., et al., Loaded Shortening, Power Output, and Rate of Force 
Redevelopment Are Increased With Knockout of Cardiac Myosin Binding Protein-
C. Circ Res, 2003. 93(8): p. 752-758. 
87. Kunst, G., et al., Myosin binding protein C, a phosphorylation-dependent force 
regulator in muscle that controls the attachment of myosin heads by its 
interaction with myosin S2. Circulation Research, 2000. 86: p. 51-58. 
88. Lakatta, E.G. and B.R. Jewell, Length-dependent activation. Circulation 
Research, 1977. 40: p. 252-257. 
89. Linari, M., et al., The structural basis of the increase in isometric force 
production with temperature in frog skeletal muscle. Journal of Physiology, 2005. 
567: p. 456-469. 
90. Litten, R.Z.r., et al., Altered myosin isozyme patterns from pressure-overloaded 
and thyrotoxic hypertrophied rabbit hearts. Circulation Research, 1982. 50(6): p. 
856-64. 
91. Loiselle, D.S., I.R. Wendt, and J.F.Y. Hoh, Energetic consequences of thyroid-
modulated shifts in ventricular isomyosin distribution in the rat. Journal of 
Muscle Research and Cell Motility, 1982. 3: p. 5-23. 
92. Lompre, A.M., B. Nadal-Ginard, and V. Mahdavi, Expression of cardiac alpha- 
and beta-myosin heavy chain genes is developmentally and hormonally regulated. 
Journal of Biological Chemistry, 1984. 259: p. 6437-6446. 
93. Lowes, B., et al., Changes in gene expression in intact human heart: 
downregulation of alpha-myosin heavy chain in hypertrophied failing ventricular 
myocardium. Journal of Clinical Investigation, 1997. 100: p. 2315-2324. 
94. Malhotra, A., et al., Expression and regulation of mutant forms of cardiac TnI in 
a reconstituted actomyosin syste: role of kinase dependent phosphorylation. 
Molecular and Cellular Biochemistry, 1997. 170: p. 99-107. 
95. Mann, D.L., et al., Cellular versus myocardial basis for the contractile 
dysfunction of hypertrophied myocardium. Circulation Research, 1991. 1991: p. 
402-415. 
96. Margossian, S.K., Reversible dissociation of dog cardiac myosin regulatory light 
chain 2 and its influence on ATP hydrolysis. Journal of Biological Chemistry, 
1985. 260: p. 13747-13754. 
 108
97. Martyn, D.A., J.F. Rondinone, and L.L. Huntsman, Myocardial segment velocity 
at a low load: time, length, and calcium dependence. American Journal of 
Physiology (Heart & Circulatory Physiology), 1983. 13: p. H708-H714. 
98. Matsubara, I. and B.M. Millman, X-ray diffraction studies on skinned single fibers 
of frog skeletal muscle. Journal of Molecular Biology, 1972. 72: p. 657-699. 
99. McDonald, K.S., Ca2+ dependence of loaded shortening in rat skinned cardiac 
myocytes and skeletal muscle fibers. Journal of Physiology, 2000. 525: p. 169-
181. 
100. McDonald, K.S., Thin filament inactivation during isotonic shortening in skinned 
striated muscle preparations. Biophysical Journal, 2000. 
101. McDonald, K.S., et al., Length dependence of Ca2+ sensitivity of tension in mouse 
cardiac myocytes expressing skeletal troponin C. Journal of Physiology, 1995. 
483: p. 131-139. 
102. McDonald, K.S. and R.L. Moss, Osmotic compression of single cardiac myocytes 
reverses the reduction in Ca2+ sensitivity of tension observed at short sarcomere 
length. Circulation Research, 1995. 77: p. 199-205. 
103. McDonald, K.S. and R.L. Moss, Strongly binding myosin cross-bridges regulate 
loaded shortening and power output in cardiac myocytes. Circulation Research, 
2000. 87: p. 768-773. 
104. McDonald, K.S., M.R. Wolff, and R.L. Moss, Sarcomere length dependence of 
the rate of tension redevelopment and submaximal tension in rat and rabbit 
skinned skeletal muscle fibers. Journal of Physiology, 1997. 501: p. 607-621. 
105. McDonald, K.S., M.R. Wolff, and R.L. Moss, Force-velocity and power-load 
curves in rat skinned cardiac myocytes. Journal of Physiology, 1998: p. 519-531. 
106. McNally, E.M., et al., Full-length rat alpha and beta cardiac myosin heavy chain 
sequences. Journal of Molecular Biology, 1989. 210: p. 665-671. 
107. Metzger, J.M., et al., Effects of myosin heavy chain isoform switching on Ca2+-
activated tension development in single adult cardiac myocytes. Circulation 
Research, 1999. 84: p. 1310-1317. 
108. Minajeva, A., et al., Titin-based contribution to shortening velocity of rabbit 
skeletal myofibrils. Journal of Physiology, 2002. 540.1: p. 177-188. 
109. Miyata, S., et al., Myosin heavy chain isoform expression in the failing and 
nonfailing human heart. Circulation Research, 2000. 86: p. 386-390. 
110. Moolman-Smook, J., et al., Identification of novel interactions between domains 
of myosin binding protein-C that are modulated by hypertrophic cardiomyopathy 
missense mutations. Circulation Research, 2002. 91: p. 704-711. 
111. Moos, C., Fluorescein microscope study of the binding of added C-protein to 
skeletal muscle myofibrils. Journal of Cellular Biology, 1981. 90: p. 25-31. 
112. Moos, C. and I.N.M. Feng, Effect of C-protein on actomyosin ATPase. 
Biochemica Biophysica ACTA, 1980. 632: p. 141-149. 
113. Moos, C., et al., The binding of skeletal muscle C-protein to F-actin, and its 
relation to the interaction of actin with myosin subfragment-1. Journal of 
Molecular Biology, 1978. 124: p. 571-586. 
114. Moos, C., et al., Interaction of C-protein with myosin, myosin rod and light 
meromyosin. Journal of Molecular Biology, 1975. 97: p. 1-9. 
 109
115. Morkin, E., I.L. Flink, and S. Goldman, Biochemical and physiologic effects of 
thyroid hormone on cardiac performance. Progress in Cardiovascular Diseases, 
1983. 25(5): p. 435-64. 
116. Moss, R.L., Sarcomere length-tension relations of frog skinned muscle fibres 
during calcium activation at short lengths. Journal of Physiology, 1979. 292: p. 
177-202. 
117. Moss, R.L., Effects of shortening velocity of rabbit skeletal muscle due to 
variations in the level of thin-filament activation. Journal of Physiology, 1986. 
377: p. 487-505. 
118. Moss, R.L., Ca2+ regulation of mechanical properties of striated muscle: 
mechanistic studies using extraction and replacement of regulatory proteins. 
Circulation Research, 1992. 70: p. 865-884. 
119. Moss, R.L., L.O. Nwoye, and M.L. Greaser, Substitution of cardiac troponin C 
into rabbit muscle does not alter the length dependence of Ca2+ sensitivity of 
tension. Journal of Physiology, 1991. 440: p. 273-289. 
120. Najad, N.S., et al., Assessment of myocardial contractility from ventricular 
pressure recordings. Cardiovascular Research, 1971. 5: p. 15-23. 
121. Nakao, K., et al., Myosin heavy chain gene expression in human heart failure. 
Journal of Clinical Investigation, 1997. 100: p. 2362-2370. 
122. Neagoe, C., et al., Gigantic variety: expression patterns of titin isoforms in 
striated muscles and consequences for myofibrillar passive stiffness. Journal of 
Muscle Research and Cell Motility, 2003. 24: p. 175-189. 
123. Nejad, N.S., et al., Assessment of myocardial contractility from ventricular 
pressure recordings. Cardiovascular Research, 1971. 5: p. 15-23. 
124. Niederlander, N., et al., Regulation of the actin-myosin interaction by titin. 
European Journal of Biochemistry, 2004. 271: p. 4572-4581. 
125. Niimura, H., et al., Mutations in the gene for cardiac myosin-binding protein C 
and late-onset familial hypertrophic cardiomyopathy. New England Journal of 
Medicine, 1998. 338: p. 1248-1257. 
126. Noland, J.R., et al., Cardiac troponin I mutants. Phosphorylation by protein 
kinases C and A and regulation of Ca2+-stimulated MgATPase of reconstituted 
actomyosin S-1. Journal of Biological Chemistry, 1995. 43: p. 25445-25454. 
127. Noland, J.R. and T.A. Kuo, Protein kinase C phosphorylation of cardiac troponin 
I or troponin T inhibits Ca2+-stimulated actomyosin MgATPase activity. Journal 
of Biological Chemistry, 1991. 266: p. 4974-4978. 
128. Noland, J.R. and T.A. Kuo, Protein kinase C phosphorylation of cardiac troponin 
T decreased Ca2+-dependent actomyosin MgATPase and troponin T binding to 
tropomyosin F-actin complex. Biochemical Journal, 1993. 288: p. 2705-2711. 
129. Offer, G., C. Moos, and R. Starr, A new protein of the thick filaments of vertebrate 
skeletal myofibrils. Journal of Molecular Biology, 1973. 74: p. 653-676. 
130. Okagaki, T., et al., The major myosin binding domain of skeletal muscle MyBP-C 
(C-protein) resides in the COOH-terminal, immunoglobin C2 repeat. Journal of 
Cell Biology, 1993. 123: p. 619-626. 
131. Pagani, E.D. and F.J. Julian, Rabbit papillary muscle myosin isozymes and the 
velocity of muscle shortening. Circulation Research, 1984. 54: p. 586-594. 
 110
132. Pagani, E.D., R. Shemin, and F.J. Julian, Tension-pCa relations of saponin-
skinned rabbit and human heart muscle. Journal of Molecular and Cellular 
Cardiology, 1986. 18: p. 55-66. 
133. Palmer, B.M., et al., Role of cardiac myosin binding protein C in sustaining left 
ventricular stiffening. Circulation Research, 2004. 94: p. 1249-1255. 
134. Palmer, B.M., et al., Reduced cross-bridge dependent stiffness of skinned 
myocardium from mice lacking cardiac myosin binding protein-C. Molecular and 
Cellular Biochemistry, 2004. 263: p. 73-80. 
135. Patel, J.R., et al., PKA accelerates rate of force development in murine skinned 
myocardium expressing alpha- or beta-tropomyosin. American Journal of 
Physiology, 2001. 280(6): p. H2732-9. 
136. Patterson, S.W., H. Piper, and E.H. Starling, The regulation of the heart beat. 
Journal of Physiology, 1914. 48: p. 465-513. 
137. Pearson, J.T., et al., In situ measurements of crossbridge dynamics and lattice 
spacing in rat hearts by X-ray diffraction: sensitivity to regional ischemia. 
Circulation, 2004. 109: p. 2976-2979. 
138. Pettigrew, J.B., Design in nature. 1908, London: Longmans, Green, and Co. 506-
518. 
139. Pi, Y., et al., Protein kinase C and A sites on troponin I regulate myofilament 
Ca2+ sensitivity and ATPase activity in the mouse myocardium. Journal of 
Physiology, 2003. 552.3: p. 845-857. 
140. Pollack, G.H. and L.L. Huntsman, Sarcomere length-active force relations in 
living mammalian cardiac muscle. American Journal of Physiology, 1974. 227: p. 
383-389. 
141. Pope, B., J.F.Y. Hoh, and A. Weeds, The ATPase activities of rat cardiac myosin 
isoenzymes. FEBS Letters, 1980. 118: p. 205-208. 
142. Pringle, J.W.S., The excitation and contraction of the flight muscles of insects. 
Journal of Physiology, 1949. 108: p. 226-232. 
143. Rayment, I., et al., Three-dimensional structure of myosin subfragment-1: a 
molecular motor. Science, 1993. 261: p. 50-58. 
144. Reconditi, M., et al., The conformation of myosin head domains in rigor muscle 
determined by X-ray interference. Biophysical Journal, 2003. 85: p. 1098-1110. 
145. Regnier, M., D.A. Martyn, and B.P. Chase, Calcium regulation of tension 
redevelopment kinetics with 2-deoxy-ATP or low [ATP] in rabbit skeletal muscle. 
Biophysical Journal, 1998. 74: p. 2005-2015. 
146. Regnier, M., et al., Thin filament near-neighbor regulatory unit interactions affect 
rabbit skeletal muscle steady-state force-Ca2+ relations. Journal of Physiology, 
2002. 540: p. 485-497. 
147. Robertson, S.P., et al., The effect of troponin I phosphorylation on the Ca2+ -
binding properties of the Ca2+-regulatory site of bovine cardiac troponin. Journal 
of Biological Chemistry, 1982. 257: p. 260-263. 
148. Rome, E., Light and X-ray diffraction studies of the filament lattice of glycerol-
extracted rabbit psoas muscle. Journal of Molecular Biology, 1967. 27: p. 591-
602. 
149. Rome, L.C., et al., Why animals have different muscle types. Nature, 1988. 335: p. 
824-827. 
 111
150. Ross, J., et al., Diastolic geometry and sarcomere lengths in the chronically 
dilated canine left ventricle. Circulation Research, 1971. 28: p. 49-61. 
151. Rundell, V.L., et al., Depressed cardiac tension cost in experimental diabetes is 
due to altered myosin heavy chain isoform expression. American Journal of 
Physiology, 2004. 287: p. H408-H413. 
152. Rundell, V.L.M., et al., Impact of {beta}-myosin heavy chain isoform expression 
on cross-bridge cycling kinetics. Am J Physiol Heart Circ Physiol, 2005. 288(2): 
p. H896-903. 
153. Sarnoff, S.J., Myocardial contractility as described by ventricular function 
curves; observations on Starling's law of the heart. Physiological Reviews, 1955. 
35: p. 107-122. 
154. Schiaffino, S., et al., Myosin changes in hypertrophied human atrial and 
ventricular myocardium.  A correlated immunofluorescence and quantitative 
immunochemical study on serial crysections. European Heart Journal, 1984. 75: p. 
95-102. 
155. Schultheiss, T., et al., Differential distribution of subsets of myofibrillar proteins 
in cardiac nonstriated and striated myofibrils. Journal of Cell Biology, 1990. 110: 
p. 1159-1172. 
156. Schwartz, K., et al., Myosin isozymic distribution correlates with speed of 
myocardial contraction. Journal of Molecular and Cellular Cardiology, 1981. 13: 
p. 1071-1075. 
157. Schwinger, R.H., et al., The failing human heart is unable to use the Frank-
Starling mechanism. Circulation Research, 1994. 74: p. 959-969. 
158. Shiner, J.S. and R.J. Solaro, The Hill coeffecient for the calcium activation of 
striated muscle contraction. Biophysical Journal, 1984. 46: p. 541-543. 
159. Skrebnitskaia, L.K., et al., Monitoring the orientation of myosin bridges on two-
dimensional maps of birefringence in a single muscle fiber. Biofizika, 2002. 47: p. 
686-690. 
160. Sonnenblick, E.H., Force-velocity relations in mammalian heart muscle. 
American Journal of Physiology, 1962. 202: p. 931-939. 
161. Starr, I., L.H. Collins, and F.C. Wood, Basal work and output of the heart in 
clinical conditions. Journal of Clinical Investigation, 1933. 12: p. 13. 
162. Starr, R. and G. Offer, The interaction of C-protein with heavy meromyosin and 
subfragment-2. Biochemical Journal, 1978. 171: p. 813-816. 
163. Stelzer, J.E., S.B. Dunning, and R.L. Moss, Ablation of myosin-binding protein-C 
accelerates stretch activation in murine skinned myocardium. Circulation 
Research, 2006. 98: p. Early online publication. 
164. Stelzer, J.E., D.P. Fitzsimons, and R.L. Moss, Ablation of myosin-binding protein-
C accelerates force development in mouse myocardium. Biophysical Journal, 
2006. 90: p. 4119-4127. 
165. Stelzer, J.E., et al., Activation dependence of stretch activation in mouse skinned 
myocardium: implications for ventricular function. Journal of General 
Physiology, 2006. 127: p. 95-107. 
166. Strang, K.T., et al., Β-adrenergic receptor stimulation increases unloaded 
shortening velocity of skinned single ventricular myocytes from rats. Circulation 
Research, 1994. 74: p. 542-549. 
 112
167. Streeter, D.D., et al., Fiber orientation in the canine left ventricle during diastole 
and systole. Circulation Research, 1969. 24: p. 339-347. 
168. Sugiura, S., et al., Comparison of unitary displacements and forces between 2 
cardiac myosin isoforms by the optical trap technique: molecular basis for 
cardiac adaptation. Circulation Research, 1998. 82: p. 1029-1034. 
169. Sumandea, M., et al., Identification of a functionally critical protein kinase C 
phosphorylation residue of cardiac troponin T. Journal of Biological Chemistry, 
2003. 278: p. 35135-35144. 
170. Sumandea, M.P., et al., Identification of a functionally critical protein kinase C 
phosphorylation residue of cardiac troponin T. Journal of Biological Chemistry, 
2003. 278: p. 35135-44. 
171. Tardiff, J.C., Sarcomeric proteins and familial hypertrophic cardiomyopathy: 
linking mutations in structural proteins to complex cardiovascular phenotypes. 
Heart Failure Reviews, 2005. 10: p. 237-248. 
172. ter Keurs, H.E.D.J., Heart failure and Starling's law of the heart. Canadian 
Journal of Cardiogy, 1996. 12: p. 1047-1057. 
173. ter Keurs, H.E.D.J., et al., Tension development and sarcomere length in rat 
cardiac trabeculae: evidence of length-dependent activation. Circulation 
Research, 1980. 46: p. 703-714. 
174. van der Velden, J., et al., Effect of protein kinase A on calcium sensitivity of force 
and its sarcomere length dependence in human cardiomyocytes. Cardiovascular 
Research, 2000. 46: p. 487-495. 
175. van der Velden, J., et al., Increased Ca2+ sensitivity of the contractile apparatus 
in end-stage human heart failure results from altered phosphorylation of 
contractile proteins. Cardiovascular Research, 2003. 57: p. 37-47. 
176. VanBuren, P., et al., Cardiac V1 and V3 myosins differ in their hydrolytic and 
mechanical activities in vitro. Circulation Research, 1995. 77: p. 439-444. 
177. Vemuri, R., et al., The stretch-activation response may be critical to the proper 
functioning of the mammalian heart. Proceedings of the National Academy of 
Sciences USA, 1999. 96: p. 1048-1053. 
178. Venema, R. and J. Kuo, Protein kinase C-mediated phosphorylation of troponin I 
and C-protein in isolated myocardial cells is associated with inhibition of 
myofibrillar actomyosin MgATPase. J. Biol. Chem., 1993. 268(4): p. 2705-2711. 
179. Wattanapermpool, J., X. Guo, and R.J. Solaro, The unique amino-terminal peptide 
of cardiac troponin I regulates myofibrillar activity only when it is 
phosphorylated. Journal of Molecular and Cellular Cardiology, 1995. 27: p. 1383-
1391. 
180. Weisberg, A. and S. Winegrad, Alteration of myosin cross-bridges by 
phosphorylation of myosin-binding protein C in cardiac muscle. Proceedings of 
the National Academy of Sciences USA, 1996. 93: p. 8999-9003. 
181. Weisberg, A. and S. Winegrad, Relation between crossbridge structure and 
actomyosin ATPase activity in rat heart. Circulation Research, 1998. 83: p. 60-72. 
182. Wick, M., Filament assembly properties of the sarcomeric myosin heavy chain. 
Research and Reviews: Meat, 2001. Special Circular 172: p. Online publication. 
183. Winegrad, S., Cardiac myosin binding protein C. Circulation Research, 1999. 84: 
p. 1117-1126. 
 113
184. Winegrad, S. and A. Weisberg, Isozyme specific modification of myosin ATPase 
by cAMP in rat heart. Circulation Research, 1987. 60: p. 384-392. 
185. Witt, C.C., et al., Hypercontractile properties of cardiac muscle fibers in a knock-
in mouse model of cardiac myosin binding protein-C. Journal of Biological 
Chemistry, 2001. 276: p. 5353-5369. 
186. Woledge, R.C., N.A. Curtin, and E. Homsher, Energetic aspects of muscle 
contraction., 1985. Academic Press, London: p. pp.47-71. 
187. Yagi, N., et al., Sarcomere-length dependence of lattice volume and radial mass 
transfer of myosin cross-bridges in rat papillary muscle. Pflugers Archive, 2004. 
448: p. 153-160. 
188. Yang, Q., et al., A mouse model of myosin binding protein C human familial 
hypertrophic cardiomyopathy. Journal of Clinical Investigation, 1998. 102(7): p. 
1292-1300. 
189. Yang, Q., et al., In vivo modeling of myosin binding protein C familial 
hypertrophic cardiomyopathy. Circulation Research, 1999. 85: p. 841-847. 
190. Zimmer, H., Who discovered the Frank-Starling mechanism? News in 
Physiological Sciences, 2002. 17: p. 181-184. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 114
 115
 
 
 
 
 
 
VITA 
 
 
 Frederick Steven Korte was born March 16th, 1975 in Boonville, MO.  He 
attended public school in Boonville, MO and graduated from Boonville High School in 
May, 1993.  He received a B.S. degree in Biochemistry from the University of Missouri- 
Columbia in December, 1997.  He married the former Ms. Amanda Elizabeth Gilbert on  
November 7th, 1998 while working for Dr. Kerry McDonald in the Department of  
Physiology at the University of Missouri.  He joined the department as a graduate student 
in August, 2001 and graduated with a Ph.D. in Physiology in July, 2006.  He will  
continue research as a postdoctoral fellow in the Department of Bioengineering at the  
University of Washington in Seattle, WA under the supervision of Dr. Michael Regnier.  
